JP4846172B2 - Flexible stent - Google Patents

Flexible stent Download PDF

Info

Publication number
JP4846172B2
JP4846172B2 JP2002056192A JP2002056192A JP4846172B2 JP 4846172 B2 JP4846172 B2 JP 4846172B2 JP 2002056192 A JP2002056192 A JP 2002056192A JP 2002056192 A JP2002056192 A JP 2002056192A JP 4846172 B2 JP4846172 B2 JP 4846172B2
Authority
JP
Japan
Prior art keywords
stent
flexible
strut
portions
cylindrical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2002056192A
Other languages
Japanese (ja)
Other versions
JP2003010340A (en
JP2003010340A5 (en
Inventor
ロバート・バーガーメイスター
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cordis Corp
Original Assignee
Cordis Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39790624&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP4846172(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US09/797,816 external-priority patent/US6942689B2/en
Priority claimed from US09/797,815 external-priority patent/US6998060B2/en
Priority claimed from US09/797,753 external-priority patent/US6790227B2/en
Application filed by Cordis Corp filed Critical Cordis Corp
Publication of JP2003010340A publication Critical patent/JP2003010340A/en
Publication of JP2003010340A5 publication Critical patent/JP2003010340A5/ja
Application granted granted Critical
Publication of JP4846172B2 publication Critical patent/JP4846172B2/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/3006Properties of materials and coating materials
    • A61F2002/3008Properties of materials and coating materials radio-opaque, e.g. radio-opaque markers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30108Shapes
    • A61F2002/3011Cross-sections or two-dimensional shapes
    • A61F2002/30112Rounded shapes, e.g. with rounded corners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30317The prosthesis having different structural features at different locations within the same prosthesis
    • A61F2002/30324The prosthesis having different structural features at different locations within the same prosthesis differing in thickness
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91508Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a difference in amplitude along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91516Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other the meander having a change in frequency along the band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91525Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other within the whole structure different bands showing different meander characteristics, e.g. frequency or amplitude
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/91533Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other characterised by the phase between adjacent bands
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91558Adjacent bands being connected to each other connected peak to peak
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91566Adjacent bands being connected to each other connected trough to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91575Adjacent bands being connected to each other connected peak to trough
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/82Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/86Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure
    • A61F2/90Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure
    • A61F2/91Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes
    • A61F2/915Stents in a form characterised by the wire-like elements; Stents in the form characterised by a net-like or mesh-like structure characterised by a net-like or mesh-like structure made from perforated sheet material or tubes, e.g. perforated by laser cuts or etched holes with bands having a meander structure, adjacent bands being connected to each other
    • A61F2002/9155Adjacent bands being connected to each other
    • A61F2002/91583Adjacent bands being connected to each other by a bridge, whereby at least one of its ends is connected along the length of a strut between two consecutive apices within a band
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0004Rounded shapes, e.g. with rounded corners
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2230/00Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2230/0002Two-dimensional shapes, e.g. cross-sections
    • A61F2230/0028Shapes in the form of latin or greek characters
    • A61F2230/0054V-shaped
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0014Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis
    • A61F2250/0036Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof having different values of a given property or geometrical feature, e.g. mechanical property or material property, at different locations within the same prosthesis differing in thickness
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0096Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers
    • A61F2250/0098Markers and sensors for detecting a position or changes of a position of an implant, e.g. RF sensors, ultrasound markers radio-opaque, e.g. radio-opaque markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Physics & Mathematics (AREA)
  • Vascular Medicine (AREA)
  • Optics & Photonics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Prostheses (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A preferred embodiment of a stent provides a folded strut section (20) that provides both structural rigidity and reduction in foreshortening of the stent mechanism. A flexible section (30) provides flexibility for delivery of the stent mechanism. In a second embodiment, flexible section columns (130) are angled with respect to each other, and to the longitudinal axis of the stent. These relatively flexible sections are oppositely phased in order to negate any torsion along their length. In yet another embodiment, the flexible connector (310) can take on an undulating shape (like an "N"), but such that the longitudinal axis of the connector is not parallel with the longitudinal axis of the stent. Finally, a new method is disclosed for making stents. The method consists of performing a standard photochemical machining process of cutting, cleaning and coating the tube with a photoresist. However, unlike former methods, the photoresist image is developed on the surface of the cylindrical metallic tube, which results in a controlled variable etching rate at selected sites on the cylindrical metallic tube during the etching process. Further embodiments provide living hinge connectors (330) and connections along the length of the radial strut member.

Description

【0001】
【発明の属する技術分野】
ステントは閉塞症を軽減するために管路の内腔の中に残される管状構造として一般的に知られている。一般的に、ステントは非拡張状態の形態で内腔の中に挿入された後に、原位置において自律的に(または第2の補助を伴って)拡張する。この拡張の典型的な方法はカテーテルに取り付けた血管形成用バルーンの使用により行なわれ、このバルーンは狭窄状態の脈管または体内通路の中で膨脹して、脈管における壁部の構成要素に付随する閉塞部分を剪断および崩壊して広げられた内腔を形成する。
【0002】
【従来の技術】
ステントが存在していない場合に、狭窄病巣部分の弾性的な反動の結果として再狭窄が生じる。これまでに、多数のステント設計が報告されているが、これらの設計は多数の制限による不都合を有していた。これらの制限はステントの寸法に関する制限を含む。
【0003】
また、別のステントが長手方向に柔軟であって一体に接続されている複数の円筒形の構成要素により構成されているステントとして報告されている。このような設計は、例えば、その設計により、ステントが湾曲部分に沿って屈曲した場合に突出したエッジ部分が生じて、動脈壁部上に堆積したプラークの上にステントが偶然的に保持される可能性が生じるという少なくとも一つの重要な不都合点を有している。また、このことにより、ステントが塞栓を形成したり位置ずれを生じ、さらに、健康な脈管の内側を損傷する可能性がある。
【0004】
このように、ステントは当業界において知られている。このようなステントはバルーンによる血管形成の際中またはその直後に拡張可能である。一般的な規則として、ステントの製造者は上記の拡張を可能にして全体の構造的完全性を達成するために軸方向の柔軟性について妥協する必要がある。
【0005】
従来のステントは2個の端部の間に一定の中間部分を伴う第1の端部および第2の端部を有している。このようなステントはさらに長手軸を有していて、複数の長手方向に配置されている帯域部分を備えており、各帯域部分が上記の長手軸に平行な線形の部分に沿って概ね連続的な波状構造を定める。さらに、複数の連結部材が各帯域を一定の管状構造に維持している。本発明の別の実施形態においては、ステントの長手方向に配置されている各帯域部分が、複数の周期的な位置において、それぞれ短い外周方向に沿う連結部材により隣接する帯域部分に接続されている。これらの帯域部分をそれぞれ伴う上記の波状構造は上記の中間部分における基本的な立体的周波数とほぼ同一の周波数を有しており、各帯域部分はそれぞれに付随する各波状構造の部分が立体的に整合されて互いにほぼ同一の位相になるように配置されている。このような立体的に整合されている各帯域部分が、複数の周期的な位置において、短い外周方向に沿う連結部材によりそれぞれ隣接する帯域部分に接続されている。
【0006】
特に、共通の軸方向の位置の第1の群における各1個の位置において、隣接している帯域部分の対の第1の組における各対の間に外周方向に沿う連結部材が存在している。
【0007】
また、共通の軸方向の位置の第2の群における各1個の位置においては、隣接している帯域部分の列の第2の組における各列の間に外周方向に沿う連結部材が存在しており、上記長手軸に沿って、一定の共通の軸方向の位置が上記第1の群および第2の群の中に交互に生じて、これら第1の組および第2の組が、任意の帯域部分が当該共通の軸方向の位置の第1の群および第2の群の一方のみにおいて隣接している帯域部分に連結されるように選択される。
【0008】
さらに、上記のステントは、当該ステント自体は全体に均一であるが、分岐状の接近を行なうように変更できる。製造者が一定の十分に大きな開口部を有するためにこのようなステントを設計する場合には、一対のステントを一方の中に他方を挿入した状態で配置できる様式で、このステントを配置することが可能になる。このような様式において、これらのステントは、任意の溶接処理または任意の特別の取り付けを伴わずに、分岐部分において配置可能である。また、上記のステント設計にインターロック機構を組み込んで、ステントを装置の組み立て中に所望の位置にインターロックするステント設計にすることができる。
【0009】
さらに、繰り返しの閉鎖ループ形状部分を含む金属製のステントが設計されている。このステントは上記の閉鎖ループが拡張中に寸法を変化しないように設計されている。このような複合的なステントは当該ステントの臨床的な性能を高める材料を各ループにより囲まれている領域に充填することにより形成されている。この材料はセラミックまたはポリマーとすることができ、永久的(使用性)または吸収性、および多孔質または非多孔質でもよく、以下のような物質、すなわち、治療剤、放射線不透過性色素、放射性材料、またはラパマイシン(rapamycin)、クラドリビン(cladribine)、ヘパリン、亜酸化窒素または任意の他の既知の薬物のいずれかあるいは組み合わせ物を含む治療剤を放出可能な材料の1種類以上を含有することができる。
【0010】
【発明が解決しようとする課題】
しかしながら、これまでに、曲がりくねった病巣部分を通過するための柔軟性ならびに体内腔の中における据え付けの後に必要な剛性を維持するための高められた支柱強度の両方を有するステントを提供することが望ましいことが分かっている。このような好ましい設計は長手方向の接続部材の波打ちにより柔軟性を提供する傾向がある。また、剛性は大体においてスロット付きの管状ステントの機構により提供されている。さらに、これらの種類のステントの特性を高めることのできる機構が存在し得ると考えられる。このようなステントは供給時において柔軟であると共に、据え付け時において剛性を示す。
【0011】
さらに、支柱部分または接続部材のいずれかにおける断面の形状部分がテーパー状(または可変)の寸法であるステントを製造可能にすることが望ましい。加えて、非長方形の断面を有するようにステントを変更することが望ましいと考えられる。なお、これら両方の場合において、異なる製造方法がこのようなステントの形成を補助できる。
【0012】
【課題を解決するための手段】
本発明の目的は比較的に少ない短縮部分を有するステントを提供することである。
【0013】
本発明の目的は一定の高められた程度の柔軟性を有するステントを提供することである。
【0014】
拡張時にステントの構造的な剛性を損なうあらゆる原因を減少しながら上記のステントを提供することである。
【0015】
本発明の別の目的はステントを製造するための新規な方法を提供することである。
【0016】
本発明の上記およびその他の目的は以下の明細書中の説明において記載されている。本明細書において説明されているように、ステントの好ましい実施形態は柔軟性の部分および折り畳み状態の支柱部分を含む装置を提供している。この折り畳み状態の支柱部分は拡張時に(花のように)開口する。この折り畳み状態の支柱部分は構造的な剛性およびステント機構における短縮の減少の両方を提供する。また、上記柔軟性の部分はステント機構の供給のための柔軟性を提供する。
【0017】
上記装置の第2の実施形態において、円柱状の部分および柔軟性の部分が存在している。この円柱状の部分は拡張時に長手方向に伸長する装置を提供する。また、柔軟性の部分は拡張時に長手方向に幾分短縮する部分を提供する。この結果、拡張中にステントの短縮または伸長が全く生じなくなる。上記柔軟性の部分の各円筒体は一方が他の一方に対して傾斜しており、さらに、ステントの長手軸に対しても傾斜して、供給中に柔軟性を提供している。さらに、この構成はバルーンに対して付加的な抵抗を加えて、供給中におけるバルーン上のステントの「ドッグボーニング(dogboning)」およびステントに沿うバルーンの滑りを防ぐ。これらの比較的に柔軟性の部分はそれぞれの長さに沿うあらゆる捩れを打ち消すために互いに対して反対向きの位相状態に配置されている。さらに、これら柔軟性の部分は従来のステントよりも一般に小さい形状でバルーン・カテーテル上にけん縮して、ステントのバルーン上における保持性を高めることができる。
【0018】
本発明のステントのさらに別の実施形態において、上記柔軟性の接続部材は(「N」字形状のような)波打ち形状を採ることができるが、ステントの長手軸に対して平行ではない。このような様式において、柔軟性はステントの長手軸とは異なる所定の軸において調整される。このような構成は、例えば、脈管内超音波装置(「IVUS」)等の既知の手段により予め決定されている特定の形態の脈管内にステントを配置することが選択される場合に望ましい。
【0019】
本発明のさらに別の実施形態において、「一体丁番(living hinge)」型の接続部材が備えられており、この部材は一般に柔軟性の接続部材を比較的に丈夫な半径方向の支柱部材に接続する。これらの一体丁番は本明細書において開示されているこれまでに説明した実施形態に見られる多数の同一の特性を達成する。先ず、これらの一体丁番は膨脹時に拡張する傾向があるので、ステントの長さの短縮化がさらに減少する。第2に、これらの一体丁番と半径方向の支柱部材との間の交点において供給される一定の組み合わされた半径方向の強度が存在している。これにより、原位置におけるよじれまたは崩壊に対してさらに抵抗する小形の「フープ(hoop)」が形成される。第3に、上記第2の特性に対する自然の結果として、上記一体丁番型の各接続部材はステントの等価な長さに沿って減少したひずみを提供する。
【0020】
本発明のステントのさらに別の好ましい実施形態において、上記半径方向の部材と接続部材との間の接続点が半径方向の支柱部分の長さに沿う一定の位置に移動する。一般的に、この接続点は支柱部分の長さに沿う任意の中間位置に配置することができる。この伸縮性の接続点を半径方向の環状部材の中間位置の近くに移動することにより、調整された様式で短縮化に対して対処できる。実際に、バルーンの相互作用を別にして、上記接続部材は短縮化を補うために伸長する必要がない。これらの伸縮性の接続部材が半径方向の環状部材の中間点に接続されていると、当該半径方向の各環状部材の間におけるステントの中間部分の距離/長さが不変に保たれる。このことは、各支柱部分における半径方向の円弧状の部分が両側から上記の中間点に近づいて移動する状態において、この中間点が比較的に同一の位置に保たれるからである。さらに、この伸縮性の接続部材の取り付け位置を支柱部分の中間点から先の反対側に移動することにより、この中間点に対してさらに近く移動している支柱部分を実際に利用することが可能になり、これにより、拡張時におけるステントを伸長することができる。
【0021】
加えて、この実施形態において、隣接している半径方向の各環状部材は未拡張状態においてそれぞれ異なる位相から始動する。その後、拡張時において、各柔軟性の接続部材における接続点の対角線状の配向により、各半径方向の環状部材はそれ自体で(同一位相に)整合する傾向がある。これにより、さらに均一な一定の空間部分が形成されて、脈管の改善された支持構造が形成できる。さらに、「波打ち状(wavy)」の支柱構造が説明されており、これにより、支柱部分自体が上記の拡張に部分的に寄与するために、支柱中間点またはその近くに柔軟性の接続部材を取り付けるための減少されたけん縮形状および拡張時における減少されたひずみの両方を促進できる。
【0022】
さらに、ステントを作成するための新規な方法を開示する。この方法において、円筒形チューブ材の新規な光化学的加工処理が提供される。この方法は切断、洗浄およびフォトレジストによるチューブ材のコーティングを含む標準的な光化学的加工処理を行なうことにより構成されている。しかしながら、従来の方法とは異なり、このフォトレジスト画像は円筒形で金属製のチューブ材の表面上において現像され、この方法により、エッチング処理中において当該円筒形で金属製のチューブ材における所定の各部位の制御された可変のエッチング速度が実現できる。このフォトレジスト画像はステントに沿う種々の距離において形成されている種々の直径を有する一連の円形領域により構成されている。この円形のフォトレジスト・パタンの直径の減少に従って、ステントに沿うこれら円形のフォトレジスト・パタンの間の距離が増大して、この装置のエッチング速度も高まる。このようなフォトレジスト・パタンの変化により、そのエッチング処理中に除去される金属(の量)に変化が生じる。
【0023】
上記の方法は円筒形で金属製のチューブ材の形状を局所的に変化するために使用できる。この方法により見られる利点はステントに沿うテーパー状の支柱部分を製造する能力である。さらに、円筒形またはその他の非長方形の断面を有する支柱部分を製造することができる。加えて、例えば、薬物を供給するためにステント内に配置される貯蔵場所を備えるために、各表面形状部分を配置することも可能である。
【0024】
上記およびその他の本発明の目的は以下の添付図面および本発明の詳細な説明により明らかになる。
【0025】
【発明の実施の形態】
図1において分かるように、一連の柔軟性の部分30が接続している一連の折り畳み状態の支柱部分20を有している円筒形のステント10が示されている。折り畳み状態の各支柱部分20は一対の端部24,26を有している概ね折り畳み状態の支柱部材25を備えている。これらの端部24,26の各対は別の折り畳み状態の支柱部材25および柔軟性の部材35の端部にも接続している。このように、1個の柔軟性の部材35における各端部34,36は1個の折り畳み状態の支柱部材25における2個の端部24,26にそれぞれ接続している。
【0026】
折り畳み状態の各支柱部材25は概して不規則なパタンを有している。一方、柔軟性の各部材35は概ね波打ち状のパタンを有している。上記の折り畳み状態の各支柱部分20はステント10の円筒形状の外周を包んでいる。また、各柔軟性の部分30もステント10の外周に沿って折り畳み状態の支柱部分20に接続している。この場合に、隣接している各柔軟性の部分30は互いに180°ずつ位相がずれて配置されていることが分かる。
【0027】
折り畳み状態の各支柱部分20の長手方向の長さはステント10の屈曲時に滑らかな外形形状を形成する程度に十分に短い。また、この折り畳み状態の支柱部分20は拡張時において一定の大きな直径方向の拡張が可能である。それゆえ、拡張時において、折り畳み状態の各支柱部分20は外周方向に拡張して、フープ状になり、最大の半径方向の強度が達成される。一方、これらの折り畳み状態の支柱部分の間に配置されている各柔軟性の部分30はステント10の未拡張状態の寸法におけるステント供給性を改善する。これらの柔軟性の部分30は長手方向に柔軟であり、拡張時における短縮化が最少にできる。
【0028】
それゆえ、使用時において、本発明のステント10はバルーン・カテーテル上に配置されて、脈管内をヘビ状に進行して、動脈内、一般的には冠状動脈内の病巣部位の中に配置される。上記柔軟性の部分30は実質的にかなり柔軟性であるので、曲がりくねった病巣部分を比較的に容易に通過できる。配置が終わると、バルーン・カテーテルが従来的な手段により拡張される。この拡張時に、上記支柱部分20における各支柱部材25が拡張してフープ状の形状が得られる。加えて、これらの部材は長手方向に拡張するので、短縮化における(寸法の)減少が打ち消される。もちろん、拡張時において、上記柔軟性の部材35が直線状になるので、このステントにより直線状で剛体の状態において強度がさらに得られる。
【0029】
本発明の変形が図2(「傾斜状態の例(angled version)」)および図3(「直線状態の例(straight version)」)におけるステント50において見ることができる。これらの例において、半径方向の各強度部分120が概ね直線状の各部材115により達成されているが、これらの部材は折り畳み状態の支柱部分を有していない。また、概ね直線状の各部材115の間の接続構造は、図1における第1の実施形態の各接続部材に関連して形成されている接続構造と極めて類似して、これら概ね直線状の各部材115をさらに柔軟性の部材125にそれぞれ接続することにより形成されている。
【0030】
短縮化を減少するための部材は傾斜した各部材130であり、これらは互いに180°位相がずれて示されている。これらの各柔軟性の部材130の間の接続構造は1個の特定の比較的に非柔軟性である部材の端部と、1個の特定の傾斜した部材130の先端部とにおいて形成されている。次に、比較的に剛体の部材115により構成されている支柱部分が拡張すると、各柔軟性の部材130の長さが短縮する。しかしながら、これらの傾斜した各部材130の長手方向の長さはステント50の長手軸に対して一定の角度で配向されている。それゆえ、拡張時において、これらの傾斜した各部材130は実際にはステント50の長手軸に対して伸長する。従って、これら全体の結果として、ステント50の拡張時に短縮化が全く生じない。
【0031】
上記の傾斜した各部材130は柔軟性を高めること、およびバルーン表面上に付加的な抵抗力を加えることの両方の目的のために傾斜している。このような構成は「ドッグボーニング(dogboning)」として知られている状態、すなわち、ステント50におけるいずれかの端部において含まれている支柱部材75のいずれかの先端エッジ部分の曝露の防止を助長する。加えて、この構成はステントのバルーン表面に沿う滑りも防止する。上記の傾斜した各部材130は互いに反対の(すなわち、180°の位相変化を有する)位相に傾斜して、ステントの長さに沿う各支柱部分75,85におけるあらゆる捩れの作用を打ち消している。これら特定の各部材は、バルーン・カテーテルの表面上におけるステントの保持性を確実に高めるために、さらに剛性の高い各部材よりも低い外形形状にけん縮することができる。さらに、本明細書において説明されているこの構成は特異的に折り畳まれた状態の形態を有していて、内腔における移動中に各支柱部分75,85のエッジ部分の「フレア状の広がり(flaring)」の危険性を減少することができる。
【0032】
なお、比較的に小さい外形形状を望む場合に、各支柱部分の長手方向の位置(「順番」)を変更することが可能である。すなわち、上記の外形形状が比較的に小さいことを望む場合に、比較的に剛性の部分120(またはその一部分)を除去して、これらを概ね傾斜した部分130に置き換えることができる。
【0033】
また、特定の支柱部分の中の各支柱部材の波の振幅は一定に維持されていないことが分かる。明細書において「W」として定められている上記の波の振幅はその形状により可能な場合に長くできる。例えば、一組の支柱部材Aと第2の組の支柱部材Bとの間に形成されている空間部分Sに注目されたい。このような特定の形態により、ステントの未拡張状態の外周の周囲に一定の増大された拡張範囲が可能になると共に、このステントの外周の周囲に配置された金属製の支柱部分に付随する適当な拡張領域が維持される。このような支柱部分の表面積の最適化はステントの拡張による病巣部分の適当な被覆を確実に行なえる点で重要である。
【0034】
上記の特定の実施形態のステント50は図1のステント10とほとんど同一の方法で拡張される。すなわち、バルーン・カテーテルにより拡張が生じる時に、傾斜した部材130が伸びてステント50の短縮化を防ぐと共に、比較的に剛性の部材120が長手方向において短縮して、完全に拡張されるステントに対して比較的に大きい剛性を示す。しかしながら、上記の両方のステント10,50の拡張において、脈管を柔軟に操縦する能力は、場合に応じて、いずれかのステント10,50の形態により高められることが理解されると考える。全ての状態において、拡張時におけるステントの短縮化の傾向が大幅に減少する。
【0035】
図4において見ることができるように、傾斜した部分を含まないステント175を備えることもできる。しかしながら、このステント175は当該ステント175の特異的な形状によりその長さに沿って減少された短縮化を伴って拡張する。この場合に、各ステント支柱部分180,190はその長手軸に沿って比較的に一定の長さを提供する。(言い換えれば、拡張状態または未拡張状態のいずれにおいても、組み合わせた状態の各支柱部分180,190の長手方向の寸法が比較的に一定に維持される。)このような様式で、拡張時において、上記ステント175はその拡張状態、未拡張状態または部分的に拡張した状態のいずれにおいても概ね一定の長さを維持する。
【0036】
図4および図5は同様のステント200の設計の別の実施形態を示している図である。この場合に、接続部材250は「N」字状の形状であり、市場において見られるフロリダ州マイアミ・レイクのCordis Corporationにより販売されているBx Velocity(登録商標)ステントの中における「N」字形状の接続部材とほとんど同一の様式であり、この接続部材は本明細書に参考文献として含まれていて共にCordis Corporationに譲渡されている2000年11月13日に出願されていて現在において米国特許第6,190,403B1号となっている米国特許出願第09/192,101号、および2000年8月10日に出願されている米国特許第09/636,071号において少なくとも部分的にその特徴が開示されている。
【0037】
上記ステント200において、図4に最良に示されているように、比較的に剛性の部分Rは長さa,bの互いに等しくない支柱部分210,220を含んでいる。さらに、図5において見られるように、この支柱部分のパタンは柔軟な各接続部材250の端部における各接合点が各支柱部分210,220に沿う任意の点に配置できるように形成されている。このような様式において、ステントが拡張すると、比較的に剛性の高い部分Rは病巣部分の表面に沿って接続部材250を「保持する(holds)」ので、ステントの引張強さ、およびこれに付随する支持が共にその病巣の各部位において高い程度で維持される。しかしながら、未拡張状態の形態においては、上記「N」字形状の柔軟性の各接続部材250が曲がりくねった冠動脈を含むほとんど全ての曲がりくねった脈管の曲がりに沿ってステント200を案内できる。
【0038】
図4および図5から分かるように、上記の別の実施形態のステント200はその全長に沿う短縮化を減少することもできる。このステントは比較的に剛性の部分Rおよび接続部材250を含む比較的に柔軟性の部分Fを含んでいる。(柔軟性の各部分Fは波うち状の長手方向に沿う接続部材250の形態である。)また、比較的に合成の各部分Rは概してスロットSの周囲における支柱部分210,220によりそれぞれ形成されているスロット状の形態を含む。これらの比較的に剛性の部分Rは上記のような組み合わせ状態の支柱部分210,220を含み、これらの支柱部分210,220はそれぞれ異なる長手方向の長さである。
【0039】
上記の各図面により分かるように、一部の半径方向に沿う位置において、各支柱部分210は比較的に長く作成されている。また、別の半径方向に沿う位置において、各支柱部分220は比較的に短く作成されている。しかしながら、これらの比較的に短い支柱部分220は長手方向に沿って、比較的に柔軟性の各接続部材250に接続している様式で、一定の長さbを有している。また、上述したように、比較的に高い剛性の各部分Rは血管形成型のバルーン・カテーテルのバルーン部分におけるこれら比較的に高い剛性の部分Rにより維持される摩擦力により比較的に高い柔軟性の各部分Fを概ね一定の長手方向の長さに維持する。従って、拡張時に、上記の一定の長さbは、比較的に柔軟性の接続部材250の概ね一定の長さと共に、ステント200が拡張する任意の直径においてこのステント200を比較的に一定の長手方向の寸法Lに維持する。また、理解されるように、この一定の長さの維持は脈管内におけるステントの確実で繰り返し可能な配置の観点から望ましい。
【0040】
さらに、図4および図5のステント200を説明するために、柔軟性の各部分Fは柔軟性の各接続部材250の挙動により動作して同様の種類の「N」字形状の柔軟性の接続部材の様式で作用する。すなわち、ステント200の柔軟性はこの領域Fに集中しているので、このような形態または構成により比較的に狭い病巣部分を移動させることができる。また、上記の比較的に強度の高い部分Rは比較的に強度の高い可塑的に変形した状態に拡張できるので、このような様式で、上記ステント200は動脈壁を支持することができる。比較的に強度の高い各部分Rにおける各支柱部分210,220の長手方向の寸法は等しくない長さであるが、このような構成は拡張状態における半径方向の支持力を低下しない。従って、このような形状のステントは病巣部位における動脈壁を適当に支持すると共に、半径方向の柔軟性および長手方向の長さを維持できると考えられる。
【0041】
図7において最良に示されているように、本発明のさらに別の実施形態を説明する。図7において、フロリダ州マイアミ・レイクのCordis Corporationにより販売されているBx Velocity(登録商標)に良く似ているステント300が含まれている。また、図7において、概ね剛性の半径方向の支柱部材320に接続されている概ね柔軟性の接続部材310がステント300に含まれている。これらの接続部材320は概して「N」字の形状に形成されており、各支柱部310は概してステントの外周の周囲において半径方向に沿う様式で形成されている。この柔軟性の各接続部材320と半径方向の各支柱部材310との間の接続は一体丁番330により形成されている。この一体丁番330は外側の半径方向の弓形部分332および内側の半径方向の弓形部分334を含む。拡張した形態において、これら半径方向の弓形部分332,334は互いに離間するように移動して、一体丁番330の全体の長さが拡張時に実際に増加する。
【0042】
血管形成用バルーン等の既知の従来的な手段、またはステント供給システム上のバルーンは本発明のステント300を拡張する。拡張時に、本発明のステント300による多数の利点が得られる。第1に、上記のように拡張した場合に、外側の半径方向の弓形部分332が実際に短縮しないので、ステント300の短縮が減少される。すなわち、この弓形部分332が僅かに伸びるので、ステント300の全長がその概ね公称の長さに維持される。また、半径方向の各弓形部分332,334が柔軟性で半径方向の各支柱部分320,310の間におけるそれぞれの接続部分において(これら内側および外側の半径方向の各弓形部分334,332の両方が)結合してこれら弓形部分の部位において優れた強度を与えるので高められた半径方向の強度が得られ、半径方向の支柱部分310がステント300における負荷方向に平行であるので半径方向に最適な強度を与えるために、このステントの外周部分Cにおいて一定の「フープ(hoop)」が形成される。また、上記半径方向の各弓形部分が比較的に大きな力を受容できるので、ステントに対応して設計された等価な強度に対応するひずみが減少される。全てにおいて、上記実施形態のステント300は現行のステントに対して比較した場合に少なくとも同等の半径方向の強度、少ない短縮化および減少されたひずみを示す。
【0043】
次に、図8,図9および図10から分かるように、本発明におけるステント400のさらに別の実施形態が示されている。この場合においても、このステント400は半径方向に沿う支柱部分410を含む概して比較的に強度の高い半径方向の部分Rを備えており、これらの支柱部分410は概してステントの外周の周囲に沿って交互に変化している様式のスロットの状態になっている。また、柔軟性の接続部材420は図7に示されている柔軟性の接続部材に類似しており、上記のBx Velocity(登録商標)ステントにおける柔軟性の接続部材にも類似している。しかしながら、これらの柔軟性の接続部材420は半径方向の各支柱部分410の中間点にほぼ近い場所においてこれら半径方向の各支柱部分に接続されている。この様式において、拡張時に、これら接続部材420の長さは半径方向の各支柱部分410の短縮または伸長にかかわらず維持される。さらに、このようにして、図9および図10における概略図から分かるように、ステントの全長が維持される。
【0044】
上記のようなステント400の長さを維持する全体の能力により、半径方向の支柱部分410は半径方向の強度の賦与のみを行ない、一方向または別の方向におけるステントの短縮化には寄与しない。また、半径方向の各支柱部分410は概ね「波打ち状(wavy)」のパタンに形成されている。この波打ち状のパタンはバルーン上のステント400のけん縮状の外形部分を減少することの補助において有用である。この効果は半径方向の各支柱部分410の柔軟性の各接続部分420への比較的に円滑な取り付けにより得られる。さらに、このような構成を形成することにより、拡張時における各支柱部分420において生じるひずみを減少することができる。このように減少したひずみは各接続部材420の各支柱部分410への接続の場所により達成できる。長手方向における各支柱部分420の移動が比較的にほとんど存在しないので、拡張時におけるこれら支柱部分において生じるひずみが比較的にほとんど存在しない。また、各支柱部分410における半径方向の弓形部分415は、ステントのバルーン上におけるけん縮をさらに容易にするために、「ずれた(shifted)」形態で理想的に配置できる。
【0045】
さらに、図8により、上記半径方向の各支柱部材410が柔軟性の各接続部材420に取り付けられて、これら柔軟性の各接続部材420がおおよそにおいてステント400の長さ方向の周囲に「螺旋形の(spiral)」パタンSに沿って進行することが分かる。柔軟性の各接続部材420における各接続点422は柔軟性を高めるために各支柱部分410において直交様式で配置されている。概して、各接続点422は支柱部分410の中間点に配置されている。さらに、これらの接続点422が支柱部分410を過ぎて(すなわち、支柱部分410の中間点から遠く離れて接続部材420の方向からずれた位置に)配置されると、公称のステント強度が上記のステントに対して比較した場合に拡張時において当然に増大する。このような構成は上述したような短縮化を減少する。さらに、この構成は、ステントをバルーン・カテーテルにより内腔に供給した時に、このステントに対して捩れの作用を全く及ぼさない。また、各支柱部分410に対するバルーンの摩擦がこれらの支柱部分410(およびこれらと反対側の各支柱部分420)を拡張中に概ね同一の半径方向の位置に維持する。ステントの捩れのあらゆる関与を減少することにより、バルーンの全体的な滑りの関与も減少される。上記の各接続部材420は互いに整合していないが、これらはバルーンの表面上においてそれぞれの位置に維持される。拡張時に、ステント400が配置されると、各支柱部分420が固定して、その内腔の中において強度が高められる。
【0046】
図8および図9から、本発明者は接続部材420が長さを維持するために重要であることが分かる。すなわち、各支柱部分410と420との間の接続の側において、接続部材420から上記中間点Mまでの距離が大きいほど、ステントの短縮化の潜在性が高まる。このことは本明細書に記載した解法が存在しない場合に、別の手段によりあらゆる短縮化を解消する必要性を生じる。
【0047】
本明細書に記載した本発明から逸脱することなく図8,図9および図10のステント400に対する種々の変更が可能であることが理解されると考える。例えば、上記の接続部材420はステント400の外周の周囲に断続的に配置されていて、半径方向の支柱部分410の全てに対して配置されていなくてもよい。また、半径方向の各支柱部分410は一連の各支柱部分410aと次の支柱部分410bとの間で概ね90°だけ位相がずれているが、これらを30°乃至150°だけずらして配置することも予想できる。また、このように配置する場合に、支柱部分410は特定の様式で屈曲するための「能力が高められ(encouraged)」、このことは特定の目的を有するステントの設計において好ましくなる可能性がある。
【0048】
上記の各ステントはレーザー・エッチング、電気的な放電加工(EDM)、光化学エッチング等の既知の従来的な手段により製造できる。しかしながら、本明細書において記載する本発明においては、ステントを作成するためのチューブの光化学的な抵抗エッチング処理を行なう新規な方法も開示されている。この新規な方法は支柱部分の三次元的に、すなわち、その長さ、外周を横切る方向、およびその深さ(または半径方向)に沿って、可変の形状を有するステントの製造を可能にする。この方法は標準的な光化学的加工処理から始まる。
【0049】
上記の新規な方法は光化学エッチングによるステントの切断工程、ステントの洗浄工程、およびその後のフォトレジストによるステントのコーティング工程により構成されている。このフォトレジスト・コーティングは、図6により理解できるように、円形の形状部分290で供給される。これらの形状部分290はそれぞれの半径の寸法を変更するために意図的に形付けられている。その後、ステントを開始する円筒形の金属チューブTの表面上にフォトレジスト画像が現像される。このフォトレジスト画像は既知の手段により制御された様式で現像される。このような様式におけるフォトレジストの現像により、円筒形の金属チューブに沿う所定の各位置における制御された可変のエッチング速度が可能になる。
【0050】
既に述べたように、新規なフォトレジスト画像が図6において見られる。このフォトレジスト画像はフォトレジスト材料310の一連の円形領域により構成されており、これらの領域は製造において望まれる可変の直径において形付けられている。また、上記の各フォトレジスト画像310は互いに可変の距離Dにおいて配置されている。この円形のフォトレジスト・パタン310の直径の減少およびその別のフォトレジスト・パタン310からの距離の増大に従って、この領域のエッチング速度が増加する。従って、このようなフォトレジスト・パタン310をステント上に意図的に配置することにより、このステントに沿う任意の方向に任意の可変の寸法を作成することができる。
【0051】
上記フォトレジスト・パタン310を変化することにより、エッチング処理中に除去されるステントの金属の量を変えることができる。この方法は金属チューブの形状を局所的に変えるために使用できる。
【0052】
上記の様式において、可変の外周方向の幅、半径方向の深さまたは長手方向の長さのステントを作成することが予想できる。従って、ステントの長さに沿って異なる柔軟性ならびに異なる強度を賦与することが可能になるので、体内の種々の位置における配置のためにステントを構成することが可能になる。
【0053】
本発明の実施態様は以下の通りである。
(A)概ね管状の形状および長手軸を有するステントにおいて、
複数の円柱状の部分および複数の柔軟性の部分を備えており、前記各部分が前記概ね管状の形状の外周の周囲に配列されていて、前記円柱状の部分の各1個が前記柔軟性の部分の少なくとも1個に取り付けられており、前記円柱状の各部分および前記柔軟性の各部分がステントの第1の未拡張状態の形態から第2の拡張状態の形態への拡張時にそれぞれの長手方向の長さを維持するステント。
(1)連続的な前記柔軟性の各部分が互いに位相ずれしている実施態様(A)に記載のステント。
(2)前記柔軟性の各部分が前記ステントの長手軸に対して平行でない一定の軸を有している実施態様(A)に記載のステント。
(3)連続的な前記柔軟性の各部分が互いに位相ずれしている実施態様(2)に記載のステント。
(4)前記柔軟性の各部分が接続部材により前記円柱状の各部分に接続しており、当該接続部材が互いに位相ずれしている実施態様(2)に記載のステント。
(5)前記柔軟性の各部分が前記ステントの長手軸に対して平行な一定の軸を有している実施態様(A)に記載のステント。
【0054】
(6)連続的な前記柔軟性の各部分が互いに位相ずれしている実施態様(5)に記載のステント。
(7)前記柔軟性の各部分が接続部材により前記円柱状の各部分に接続しており、当該接続部材が互いに位相ずれしている実施態様(5)に記載のステント。
(8)前記柔軟性の各部分が接続部材により前記円柱状の各部分に接続しており、当該接続部材が互いに位相ずれしている実施態様(A)に記載のステント。
【0055】
【発明の効果】
従って、本発明によれば、比較的に少ない短縮部分を有するステント、一定の高められた程度の柔軟性を有するステント、および拡張時にステントの構造的な剛性を損なうあらゆる原因を減少できるステントが提供でき、さらにこれらのステントを製造するための新規な方法が提供できる。
【図面の簡単な説明】
【図1】本発明を実施しているステントの平面図である。
【図2】本発明の別の実施形態の平面図である。
【図3】本発明の別の実施形態の平面図である。
【図4】本発明のステントのさらに別の実施形態の平面図である。
【図5】図4の線b−bに沿う図4における同一断面の拡大図である。
【図6】本発明において説明されているステントを作成するための方法を実行するためにステント上に形成されているフォトレジスト・パタンの概略図である。
【図7】本発明のさらに別の実施形態の平面図である。
【図8】本発明のさらに別の実施形態の平面図である。
【図9】図8のステントの理論的な後方の拡張の概略図である。
【図10】図8のステントの理論的な後方の拡張の概略図である。
【符号の説明】
10 円筒形のステント
20 支柱部分
30 柔軟性の部分
24,26 支柱部材における一対の端部
25 支柱部材
34,36 柔軟性の部材における各端部
35 柔軟性の部材
[0001]
BACKGROUND OF THE INVENTION
Stents are commonly known as tubular structures that are left in the lumen of a duct to reduce occlusion. Generally, a stent expands autonomously (or with a second aid) in situ after being inserted into the lumen in an unexpanded form. A typical method of dilation is through the use of an angioplasty balloon attached to a catheter, which is inflated in a stenotic vessel or body passage and attached to a wall component in the vessel. The occluded part is sheared and collapsed to form an expanded lumen.
[0002]
[Prior art]
In the absence of a stent, restenosis occurs as a result of elastic recoil of the stenotic lesion. To date, a number of stent designs have been reported, but these designs have the disadvantages of a number of limitations. These limitations include limitations on the dimensions of the stent.
[0003]
Another stent has been reported as a stent composed of a plurality of cylindrical components that are flexible in the longitudinal direction and connected together. Such a design, for example, results in a protruding edge portion when the stent is bent along a curved portion, and the stent is accidentally retained on plaque deposited on the arterial wall. It has at least one important disadvantage that arises. This can also cause the stent to become embolized or misaligned, further damaging the inside of a healthy vessel.
[0004]
Thus, stents are known in the art. Such stents can be expanded during or immediately after balloon angioplasty. As a general rule, stent manufacturers need to compromise on axial flexibility to allow for the expansion described above and to achieve overall structural integrity.
[0005]
A conventional stent has a first end and a second end with an intermediate portion between the two ends. Such a stent further has a longitudinal axis and comprises a plurality of longitudinally disposed zone portions, each zone portion being generally continuous along a linear portion parallel to the longitudinal axis. A wavy structure. Further, a plurality of connecting members maintain each band in a constant tubular structure. In another embodiment of the present invention, each band portion arranged in the longitudinal direction of the stent is connected to an adjacent band portion by a connecting member along a short outer circumferential direction at a plurality of periodic positions. . The wavy structure with each of these band portions has substantially the same frequency as the basic three-dimensional frequency in the middle portion, and each band portion has a three-dimensional portion of each wavy structure associated with it. Are arranged so as to have substantially the same phase. Each of the three-dimensionally aligned band portions is connected to the adjacent band portions by connecting members along the short outer peripheral direction at a plurality of periodic positions.
[0006]
In particular, at each one position in the first group of common axial positions, there is a connecting member along the outer circumferential direction between each pair in the first set of adjacent band portion pairs. Yes.
[0007]
Further, at each one position in the second group of common axial positions, there is a connecting member along the outer circumferential direction between each row in the second set of adjacent band portion rows. And along the longitudinal axis, a certain common axial position is alternately generated in the first group and the second group, and the first group and the second group are arbitrary. Are selected to be connected to adjacent band portions in only one of the first group and the second group at the common axial position.
[0008]
Furthermore, the stent described above is uniform throughout, but can be modified to provide a bifurcated approach. If the manufacturer designs such a stent to have a certain sufficiently large opening, place the stent in such a way that a pair of stents can be placed with one inserted into the other. Is possible. In such a manner, these stents can be placed at the bifurcation without any welding process or any special attachment. Also, an interlock mechanism can be incorporated into the stent design described above, resulting in a stent design that interlocks the stent at a desired location during device assembly.
[0009]
In addition, metallic stents have been designed that include repeated closed loop shaped portions. This stent is designed so that the closed loop does not change dimensions during expansion. Such composite stents are formed by filling the area surrounded by each loop with a material that enhances the clinical performance of the stent. This material can be ceramic or polymer and can be permanent (usable) or absorbable and porous or non-porous, such as: therapeutic agents, radiopaque dyes, radioactive Contain one or more materials capable of releasing a therapeutic agent, including any material or combination of rapamycin, cladribine, heparin, nitrous oxide or any other known drug it can.
[0010]
[Problems to be solved by the invention]
To date, however, it is desirable to provide a stent that has both the flexibility to pass through tortuous lesions and the increased strut strength to maintain the necessary stiffness after installation in a body lumen. I know that. Such preferred designs tend to provide flexibility due to the undulation of the longitudinal connecting members. Rigidity is also largely provided by a slotted tubular stent mechanism. It is further believed that there may be mechanisms that can enhance the properties of these types of stents. Such stents are flexible when delivered and exhibit rigidity when installed.
[0011]
It is further desirable to be able to produce a stent where the cross-sectional shape of either the strut portion or the connecting member is a tapered (or variable) dimension. In addition, it may be desirable to modify the stent to have a non-rectangular cross section. It should be noted that in both cases, different manufacturing methods can assist in the formation of such a stent.
[0012]
[Means for Solving the Problems]
An object of the present invention is to provide a stent having relatively few shortened portions.
[0013]
The object of the present invention is to provide a stent with a certain increased degree of flexibility.
[0014]
It is to provide a stent as described above while reducing any cause that compromises the structural rigidity of the stent upon expansion.
[0015]
Another object of the present invention is to provide a novel method for manufacturing stents.
[0016]
  These and other objects of the present invention are described in the following description. As described herein, a preferred embodiment of a stent is a flexible portion and a fold.FoldingAn apparatus is provided that includes a state strut portion. This foldFoldingThe column part in the state opens when expanded (like a flower). This foldFoldingThe state strut portion provides both structural rigidity and reduced shortening in the stent mechanism. The flexible portion also provides flexibility for delivery of the stent mechanism.
[0017]
In a second embodiment of the device, a cylindrical part and a flexible part are present. This cylindrical portion provides a device that extends longitudinally when expanded. The flexible portion also provides a portion that shortens somewhat in the longitudinal direction when expanded. This results in no stent shortening or stretching during expansion. One of the cylinders of the flexible portion is inclined with respect to the other, and is also inclined with respect to the longitudinal axis of the stent to provide flexibility during delivery. In addition, this configuration adds additional resistance to the balloon to prevent “dogboning” of the stent on the balloon during delivery and slipping of the balloon along the stent. These relatively flexible portions are placed in a phase state opposite to each other to counteract any twist along their respective lengths. In addition, these flexible portions can be crimped onto the balloon catheter in a generally smaller shape than conventional stents to increase the retention of the stent on the balloon.
[0018]
In yet another embodiment of the stent of the present invention, the flexible connecting member may take a corrugated shape (such as an “N” shape) but is not parallel to the longitudinal axis of the stent. In such a manner, the flexibility is adjusted in a predetermined axis that is different from the longitudinal axis of the stent. Such a configuration is desirable when it is selected to place a stent within a particular form of vessel that is predetermined by known means such as, for example, an intravascular ultrasound device (“IVUS”).
[0019]
In yet another embodiment of the present invention, a “living hinge” type connection member is provided, which generally turns a flexible connection member into a relatively strong radial strut member. Connecting. These integral hinges achieve a number of identical characteristics found in the embodiments described hereinbefore disclosed herein. First, because these integral hinges tend to expand upon expansion, the shortening of the stent length is further reduced. Second, there is a certain combined radial strength supplied at the intersection between these integral hinges and the radial strut members. This creates a small “hoop” that further resists kinking or collapse in situ. Third, as a natural consequence of the second property, each of the integral hinge connecting members provides a reduced strain along the equivalent length of the stent.
[0020]
In yet another preferred embodiment of the stent of the present invention, the connection point between the radial member and the connecting member moves to a fixed position along the length of the radial strut portion. In general, this connection point can be located at any intermediate position along the length of the column portion. By moving this elastic connection point closer to the middle position of the radial annular member, the shortening can be addressed in a coordinated manner. In fact, apart from the balloon interaction, the connecting member need not extend to compensate for the shortening. When these stretchable connecting members are connected to the midpoints of the radial annular members, the distance / length of the intermediate portion of the stent between the radial annular members remains unchanged. This is because the intermediate point is maintained at a relatively same position in a state in which the arc-shaped portion in the radial direction of each column portion moves from both sides to approach the intermediate point. Furthermore, by moving the attachment position of this stretchable connecting member from the middle point of the column part to the opposite side, it is possible to actually use the column part that is moving closer to this middle point. Thus, the stent at the time of expansion can be expanded.
[0021]
In addition, in this embodiment, each adjacent radial annular member starts from a different phase in the unexpanded state. Thereafter, during expansion, each radial ring member tends to align itself (in the same phase) due to the diagonal orientation of the connection points in each flexible connection member. As a result, a more uniform and constant space portion is formed, and an improved support structure of the vessel can be formed. Furthermore, a “wavy” strut structure is described, which allows a flexible connecting member at or near the strut midpoint in order for the strut portion itself to partially contribute to the expansion described above. Both reduced crimp shape for mounting and reduced strain on expansion can be promoted.
[0022]
Furthermore, a novel method for making a stent is disclosed. In this way, a novel photochemical processing of cylindrical tube material is provided. This method consists of performing standard photochemical processing including cutting, cleaning and coating the tube with photoresist. However, unlike the conventional method, the photoresist image is developed on the surface of the cylindrical metal tube material, and this method allows each of the predetermined images on the cylindrical metal tube material during the etching process. A controlled and variable etching rate of the part can be realized. The photoresist image is made up of a series of circular regions having various diameters that are formed at various distances along the stent. As the diameter of the circular photoresist pattern decreases, the distance between the circular photoresist patterns along the stent increases and the etch rate of the device also increases. Such a change in the photoresist pattern causes a change in the amount of metal that is removed during the etching process.
[0023]
The above method can be used to locally change the shape of the cylindrical and metallic tube material. An advantage seen with this method is the ability to produce a tapered strut portion along the stent. Furthermore, post portions having a cylindrical or other non-rectangular cross-section can be manufactured. In addition, each surface feature can be positioned, for example, to provide a storage location that is positioned within the stent to deliver the drug.
[0024]
These and other objects of the present invention will become apparent from the following accompanying drawings and detailed description of the invention.
[0025]
DETAILED DESCRIPTION OF THE INVENTION
  As can be seen in FIG. 1, a series of folds connected by a series of flexible portions 30.FoldingA cylindrical stent 10 is shown having a strut portion 20 in a state. FoldFoldingEach column portion 20 in the state has a pair of ends 24, 26 and is generally folded.FoldingThe column member 25 in a state is provided. Each pair of these ends 24, 26 is a separate foldFoldingIt is also connected to the ends of the column member 25 and the flexible member 35 in the state. Thus, each end 34, 36 of one flexible member 35 is folded one.FoldingThey are connected to the two end portions 24 and 26 of the column member 25 in the state.
[0026]
  FoldFoldingEach strut member 25 in the state has a generally irregular pattern. On the other hand, each flexible member 35 has a generally wavy pattern. Fold aboveFoldingEach strut portion 20 in the state wraps around the cylindrical outer periphery of the stent 10. Each flexible portion 30 is also folded along the outer periphery of the stent 10.FoldingIt is connected to the column part 20 in the state. In this case, it can be seen that the adjacent flexible portions 30 are arranged 180 degrees out of phase with each other.
[0027]
  FoldFoldingThe length of each strut portion 20 in the longitudinal direction is sufficiently short to form a smooth outer shape when the stent 10 is bent. Also this foldFoldingThe column portion 20 in the state can be expanded in a large diameter direction at the time of expansion. Therefore, when expanding,FoldingEach strut portion 20 in the state expands in the outer circumferential direction to form a hoop shape, and maximum radial strength is achieved. Meanwhile, theseFoldingEach flexible portion 30 disposed between the state strut portions improves stent delivery in the unexpanded dimensions of the stent 10. These flexible portions 30 are flexible in the longitudinal direction, and shortening during expansion can be minimized.
[0028]
Thus, in use, the stent 10 of the present invention is placed on a balloon catheter and travels in a snake-like manner within a vessel and placed within a artery, typically a lesion site within a coronary artery. The The flexible portion 30 is substantially flexible so that it can pass through a tortuous lesion portion relatively easily. Once deployed, the balloon catheter is expanded by conventional means. At the time of expansion, each column member 25 in the column part 20 is expanded to obtain a hoop-like shape. In addition, since these members expand in the longitudinal direction, the reduction in size is reduced. Of course, since the flexible member 35 becomes linear at the time of expansion, the stent can further provide strength in a linear and rigid state.
[0029]
  Variations of the present invention can be seen in the stent 50 in FIG. 2 (“angled version”) and FIG. 3 (“straight version”). In these examples, each strength portion 120 in the radial direction is achieved by each member 115 being generally linear, but these members are folded.FoldingIt does not have a state column part. In addition, the connection structure between the substantially linear members 115 is very similar to the connection structure formed in relation to the connection members of the first embodiment in FIG. It is formed by connecting the member 115 to the flexible member 125 respectively.
[0030]
The members for reducing the shortening are the respective inclined members 130, which are shown 180 degrees out of phase with each other. The connection structure between each of these flexible members 130 is formed at the end of one particular relatively inflexible member and the tip of one particular inclined member 130. Yes. Next, when the column portion constituted by the relatively rigid member 115 is expanded, the length of each flexible member 130 is shortened. However, the longitudinal length of each of these inclined members 130 is oriented at a constant angle with respect to the longitudinal axis of the stent 50. Therefore, when expanded, each of these inclined members 130 actually extends relative to the longitudinal axis of the stent 50. Thus, as a result of these overall, no shortening occurs when the stent 50 is expanded.
[0031]
  Each of the tilted members 130 is tilted for the purposes of both increasing flexibility and applying additional resistance on the balloon surface. Such a configuration helps prevent exposure of any leading edge portion of the strut member 75 contained at either end of the stent 50, known as "dogboning". To do. In addition, this configuration prevents slippage along the balloon surface of the stent. Each of the tilted members 130 is tilted in opposite phases (ie, having a 180 ° phase change) to counteract any twisting effects in each strut portion 75, 85 along the length of the stent. Each of these specific members can be crimped to a lower profile than the more rigid members to ensure increased retention of the stent on the balloon catheter surface. Furthermore, this configuration described herein is specifically folded.TatamiAnd can reduce the risk of “flaring” of the edge portion of each strut portion 75, 85 during movement in the lumen.
[0032]
When a relatively small outer shape is desired, the position (“order”) in the longitudinal direction of each column portion can be changed. That is, if it is desired that the outer shape be relatively small, the relatively rigid portions 120 (or portions thereof) can be removed and replaced with generally inclined portions 130.
[0033]
Moreover, it turns out that the amplitude of the wave of each support | pillar member in a specific support | pillar part is not maintained constant. The amplitude of the wave, which is defined as “W” in the specification, can be increased if possible due to its shape. For example, note the space portion S formed between one set of strut members A and a second set of strut members B. Such a particular configuration allows a certain increased extent of expansion around the unexpanded outer periphery of the stent and is suitable for the metal strut portion disposed around the outer periphery of the stent. Extended area is maintained. Such optimization of the surface area of the strut portion is important in that an appropriate covering of the lesion portion can be ensured by expanding the stent.
[0034]
The stent 50 of the particular embodiment described above is expanded in much the same way as the stent 10 of FIG. That is, when expansion is caused by the balloon catheter, the angled member 130 extends to prevent shortening of the stent 50, and the relatively rigid member 120 shortens in the longitudinal direction to provide a fully expanded stent. Relatively large rigidity. However, it will be understood that in the expansion of both stents 10, 50 described above, the ability to flexibly maneuver the vessel is enhanced by the configuration of either stent 10, 50, as the case may be. In all conditions, the tendency to shorten the stent during expansion is greatly reduced.
[0035]
As can be seen in FIG. 4, a stent 175 may also be provided that does not include an inclined portion. However, the stent 175 expands with a shortening that is reduced along its length due to the unique shape of the stent 175. In this case, each stent strut portion 180, 190 provides a relatively constant length along its longitudinal axis. (In other words, the longitudinal dimension of each post portion 180, 190 in the combined state is maintained relatively constant in either the expanded state or the unexpanded state.) The stent 175 maintains a generally constant length in any of its expanded state, unexpanded state, or partially expanded state.
[0036]
4 and 5 show another embodiment of a similar stent 200 design. In this case, the connecting member 250 has an “N” shape, and the “N” shape in the Bx Velocity® stent sold by Cordis Corporation of Miami Lake, Florida, found on the market. This connecting member was filed on November 13, 2000, which is hereby incorporated by reference and assigned to Cordis Corporation, and is now a U.S. Pat. No. 6,190,403B1, US patent application Ser. No. 09 / 192,101, and US patent application Ser. No. 09 / 636,071 filed Aug. 10, 2000, at least in part. It is disclosed.
[0037]
In the stent 200, as best shown in FIG. 4, the relatively rigid portion R includes strut portions 210, 220 that are not equal in length a, b. Further, as can be seen in FIG. 5, the pattern of the column portion is formed so that each joint point at the end of each flexible connecting member 250 can be arranged at any point along each column portion 210, 220. . In such a manner, when the stent is expanded, the relatively stiff portion R "holds" the connecting member 250 along the surface of the lesion portion, so that the tensile strength of the stent and its associated Both support is maintained to a high degree at each site of the lesion. However, in the unexpanded configuration, each of the “N” shaped flexible connecting members 250 can guide the stent 200 along almost any tortuous vessel bend including the tortuous coronary artery.
[0038]
As can be seen from FIGS. 4 and 5, the stent 200 of another embodiment described above can also reduce shortening along its entire length. The stent includes a relatively rigid portion R that includes a relatively rigid portion R and a connecting member 250. (Each flexible portion F is in the form of a connecting member 250 along the wave-like longitudinal direction.) Also, each relatively synthetic portion R is generally formed by strut portions 210 and 220 around the slot S, respectively. Including a slot-shaped configuration. These relatively rigid portions R include the strut portions 210, 220 in the combined state as described above, and the strut portions 210, 220 each have a different longitudinal length.
[0039]
As can be seen from each of the above drawings, each column portion 210 is formed relatively long at a position along a part of the radial direction. Each strut portion 220 is made relatively short at a position along another radial direction. However, these relatively short strut portions 220 have a constant length b in a manner that connects to each relatively flexible connecting member 250 along the longitudinal direction. Also, as described above, each relatively rigid portion R is relatively flexible due to the frictional force maintained by these relatively rigid portions R in the balloon portion of an angioplasty balloon catheter. Each portion F is maintained at a substantially constant longitudinal length. Thus, when expanded, the constant length b, together with the generally constant length of the relatively flexible connecting member 250, causes the stent 200 to have a relatively constant longitudinal length at any diameter that the stent 200 expands. Maintain directional dimension L. Also, as will be appreciated, maintaining this constant length is desirable in terms of a reliable and repeatable placement of the stent within the vessel.
[0040]
Further, to illustrate the stent 200 of FIGS. 4 and 5, each flexible portion F operates according to the behavior of each flexible connecting member 250 to provide a similar type of “N” shaped flexible connection. Acts in the form of members. That is, since the flexibility of the stent 200 is concentrated in this region F, a relatively narrow lesion portion can be moved by such a form or configuration. In addition, since the relatively high strength portion R can be expanded to a relatively high strength plastically deformed state, the stent 200 can support the artery wall in this manner. Although the longitudinal dimensions of the column portions 210 and 220 in the relatively strong portions R are unequal, such a configuration does not reduce the radial support force in the expanded state. Therefore, it is considered that the stent having such a shape can appropriately support the artery wall at the lesion site and can maintain the radial flexibility and the longitudinal length.
[0041]
As best shown in FIG. 7, yet another embodiment of the present invention will be described. In FIG. 7, a stent 300 is included that resembles Bx Velocity® sold by Cordis Corporation of Miami Lake, Florida. In FIG. 7, the stent 300 also includes a generally flexible connecting member 310 that is connected to a generally rigid radial strut member 320. These connecting members 320 are generally formed in an “N” shape, and each strut 310 is generally formed in a radial fashion around the outer periphery of the stent. The connection between each flexible connecting member 320 and each radial strut member 310 is formed by an integral hinge 330. The integral hinge 330 includes an outer radial arcuate portion 332 and an inner radial arcuate portion 334. In the expanded configuration, these radial arcuate portions 332, 334 move away from each other, and the overall length of the integral hinge 330 actually increases upon expansion.
[0042]
Known conventional means, such as an angioplasty balloon, or a balloon on a stent delivery system expands the stent 300 of the present invention. Upon expansion, a number of advantages are gained by the stent 300 of the present invention. First, when expanded as described above, the shortening of the stent 300 is reduced because the outer radial arcuate portion 332 does not actually shorten. That is, the arcuate portion 332 extends slightly so that the overall length of the stent 300 is maintained at its generally nominal length. Also, each arcuate portion 332, 334 in the radial direction is flexible and in a respective connection portion between each strut portion 320, 310 in the radial direction (both these inner and outer radial arcuate portions 334, 332 ) To provide superior strength at the site of these arcuate portions, resulting in increased radial strength, and since the radial strut portions 310 are parallel to the loading direction on the stent 300, optimal radial strength is achieved. In order to provide a constant “hoop” at the outer peripheral portion C of the stent. Also, since each of the radial arcuate portions can accept a relatively large force, strain corresponding to an equivalent strength designed for the stent is reduced. In all, the stent 300 of the above embodiment exhibits at least equivalent radial strength, reduced shortening and reduced strain when compared to current stents.
[0043]
Next, as can be seen from FIGS. 8, 9 and 10, yet another embodiment of a stent 400 in accordance with the present invention is shown. Again, the stent 400 includes a generally relatively strong radial portion R that includes strut portions 410 along the radial direction, the strut portions 410 generally extending around the circumference of the stent. It is in the state of a slot that is changing alternately. The flexible connecting member 420 is similar to the flexible connecting member shown in FIG. 7 and is also similar to the flexible connecting member in the Bx Velocity® stent described above. However, these flexible connecting members 420 are connected to each of the radial strut portions at a location that is approximately near the midpoint of each radial strut portion 410. In this manner, upon expansion, the lengths of these connecting members 420 are maintained regardless of the shortening or extension of each strut portion 410 in the radial direction. Furthermore, in this way, the overall length of the stent is maintained, as can be seen from the schematics in FIGS.
[0044]
Due to the overall ability to maintain the length of the stent 400 as described above, the radial strut portion 410 only provides radial strength and does not contribute to shortening the stent in one or another direction. Also, each strut portion 410 in the radial direction is generally formed in a “wavy” pattern. This wavy pattern is useful in assisting in reducing the crimped profile of the stent 400 on the balloon. This effect is obtained by a relatively smooth attachment of each strut portion 410 in the radial direction to each flexible connection portion 420. Furthermore, by forming such a configuration, it is possible to reduce the distortion generated in each column portion 420 during expansion. Such reduced strain can be achieved by the location of connection of each connecting member 420 to each strut portion 410. Since there is relatively little movement of each post portion 420 in the longitudinal direction, there is relatively little distortion that occurs in these post portions during expansion. Also, the radial arcuate portion 415 in each strut portion 410 can be ideally placed in a “shifted” configuration to further facilitate crimping on the stent balloon.
[0045]
Further, according to FIG. 8, the radial strut members 410 are attached to the flexible connecting members 420, and the flexible connecting members 420 are approximately “spiral” around the length of the stent 400. It can be seen that it proceeds along the “spiral” pattern S. Each connection point 422 in each flexible connection member 420 is arranged in an orthogonal manner in each post portion 410 to increase flexibility. In general, each connection point 422 is located at an intermediate point of the post portion 410. Further, when these connection points 422 are positioned past the strut portion 410 (ie, at a location far from the midpoint of the strut portion 410 and offset from the direction of the connection member 420), the nominal stent strength is as described above. Naturally increases on expansion when compared to a stent. Such a configuration reduces the shortening as described above. In addition, this configuration has no twisting effect on the stent when it is delivered to the lumen by a balloon catheter. Balloon friction against each strut portion 410 also maintains these strut portions 410 (and their respective strut portions 420) in generally the same radial position during expansion. By reducing any involvement of stent twist, the overall slippage of the balloon is also reduced. The connecting members 420 are not aligned with each other, but they are maintained in their respective positions on the surface of the balloon. Upon expansion, when the stent 400 is deployed, each strut portion 420 is secured to increase strength within its lumen.
[0046]
8 and 9, the inventor finds that the connecting member 420 is important for maintaining the length. That is, on the connection side between the strut portions 410 and 420, the greater the distance from the connection member 420 to the intermediate point M, the greater the potential for shortening the stent. This creates a need to eliminate any shortening by other means in the absence of the solution described herein.
[0047]
It will be understood that various modifications can be made to the stent 400 of FIGS. 8, 9 and 10 without departing from the invention described herein. For example, the connection member 420 described above is intermittently disposed around the outer periphery of the stent 400 and may not be disposed with respect to all of the radial strut portions 410. Also, each strut portion 410 in the radial direction is out of phase by approximately 90 ° between each strut portion 410a and the next strut portion 410b, but these are shifted by 30 ° to 150 °. Can also be expected. Also, in this arrangement, the strut portion 410 is “encouraged” to bend in a particular manner, which may be preferred in the design of a stent with a particular purpose. .
[0048]
Each of the above stents can be manufactured by known conventional means such as laser etching, electrical discharge machining (EDM), photochemical etching and the like. However, the present invention described herein also discloses a novel method of performing a photochemical resistance etching process on a tube for making a stent. This novel method allows for the manufacture of stents having a variable shape in three dimensions, ie, along their length, direction across the circumference, and along their depth (or radial direction). This method begins with standard photochemical processing.
[0049]
The above-described novel method includes a stent cutting step by photochemical etching, a stent cleaning step, and a subsequent step of coating the stent with a photoresist. This photoresist coating is provided in a circular shaped portion 290, as can be seen in FIG. These shaped portions 290 are intentionally shaped to change the size of their respective radii. A photoresist image is then developed on the surface of the cylindrical metal tube T that initiates the stent. The photoresist image is developed in a controlled manner by known means. Development of the photoresist in this manner allows for a controlled and variable etch rate at each predetermined location along the cylindrical metal tube.
[0050]
As already mentioned, a new photoresist image can be seen in FIG. The photoresist image is made up of a series of circular regions of photoresist material 310 that are shaped at variable diameters desired in manufacturing. The photoresist images 310 are arranged at a variable distance D from each other. As the diameter of this circular photoresist pattern 310 decreases and its distance from another photoresist pattern 310 increases, the etch rate of this region increases. Thus, by intentionally placing such a photoresist pattern 310 on the stent, any variable dimension can be created in any direction along the stent.
[0051]
By varying the photoresist pattern 310, the amount of stent metal removed during the etching process can be varied. This method can be used to locally change the shape of the metal tube.
[0052]
In the above manner, it can be envisaged to create a stent with variable circumferential width, radial depth or longitudinal length. Thus, different flexibility as well as different strengths can be provided along the length of the stent, allowing the stent to be configured for placement at various locations within the body.
[0053]
  Embodiments of the present invention are as follows.
  (A) In a stent having a generally tubular shape and a longitudinal axis,
A plurality of cylindrical portions and a plurality of flexible portions, wherein each of the portions is arranged around an outer periphery of the generally tubular shape, and each one of the cylindrical portions is the flexible portion. Each of the cylindrical portions and the flexible portions of each of the portions when expanded from a first unexpanded configuration to a second expanded configuration. A stent that maintains its longitudinal length.
  (1) The continuous flexible portions are out of phase with each other.Embodiment (A)The stent according to 1.
  (2) Each portion of the flexibility has a fixed axis that is not parallel to the longitudinal axis of the stent.Embodiment (A)The stent according to 1.
  (3) The stent according to embodiment (2), wherein the continuous portions of the flexibility are out of phase with each other.
  (4) The stent according to the embodiment (2), in which the flexible portions are connected to the cylindrical portions by a connecting member, and the connecting members are out of phase with each other.
  (5) Each portion of the flexibility has a constant axis parallel to the longitudinal axis of the stent.Embodiment (A)The stent according to 1.
[0054]
  (6) The stent according to embodiment (5), wherein the continuous portions of flexibility are out of phase with each other.
  (7) The stent according to the embodiment (5), wherein the flexible portions are connected to the cylindrical portions by a connecting member, and the connecting members are out of phase with each other.
  (8) The flexible portions are connected to the cylindrical portions by connecting members, and the connecting members are out of phase with each other.Embodiment (A)The stent according to 1.
[0055]
【The invention's effect】
Accordingly, the present invention provides a stent having relatively few shortened portions, a stent having a certain degree of increased flexibility, and a stent that can reduce any cause of loss of the structural rigidity of the stent when expanded. In addition, novel methods for manufacturing these stents can be provided.
[Brief description of the drawings]
FIG. 1 is a plan view of a stent embodying the present invention.
FIG. 2 is a plan view of another embodiment of the present invention.
FIG. 3 is a plan view of another embodiment of the present invention.
FIG. 4 is a plan view of yet another embodiment of the stent of the present invention.
5 is an enlarged view of the same cross section in FIG. 4 along the line bb in FIG. 4;
FIG. 6 is a schematic view of a photoresist pattern formed on a stent to perform the method for making a stent described in the present invention.
FIG. 7 is a plan view of still another embodiment of the present invention.
FIG. 8 is a plan view of still another embodiment of the present invention.
9 is a schematic view of theoretical posterior expansion of the stent of FIG. 8. FIG.
10 is a schematic view of the theoretical posterior expansion of the stent of FIG. 8. FIG.
[Explanation of symbols]
10 Cylindrical stent
20 Prop part
30 Flexible part
24, 26 A pair of end portions in the column member
25 Prop member
34, 36 Ends of flexible member
35 Flexible members

Claims (2)

概ね管状の形状および長手軸を有するステントにおいて、
複数の円柱状の区域であって、それぞれの円柱状の区域が複数の概ね折り重ね状態の支柱部材を備える円柱状の区域および、複数の柔軟性の区域であって、それぞれの柔軟性の区域が複数の概ね折り重ね状態の柔軟性の部材を備える柔軟性の区域を備えており、
前記各区域が前記概ね管状の形状の円周に沿って配列されていて、前記円柱状の区域の各1個が前記柔軟性の区域の少なくとも1個に取り付けられており、前記ステントの長手方向において1個の柔軟性の区域が2個の隣接する円柱状の区域の間にあり、前記長手方向に見た場合に、一つの柔軟性の区域の概ね折り重ね状態の柔軟性の部材が、隣接する柔軟性の区域の概ね折り重ね状態の柔軟性の部材に対して、反対の位相に傾斜しており、
ステントの第1の未拡張状態の形態から第2の拡張状態の形態への拡張時に、前記柔軟性の各区域が、長手方向に短縮すると共に前記傾斜に起因して伸張もし、ステント全体の長手方向の長さが維持される、
ステント。
In a stent having a generally tubular shape and a longitudinal axis,
A plurality of cylindrical areas, each cylindrical area comprising a plurality of generally folded strut members, and a plurality of flexible areas, each flexible area Comprises a flexible region comprising a plurality of generally folded flexible members;
Each of the zones is arranged along a circumference of the generally tubular shape, and each one of the cylindrical zones is attached to at least one of the flexible zones, the longitudinal direction of the stent; A flexible region is between two adjacent cylindrical regions, and when viewed in the longitudinal direction, the flexible member in a generally folded state of one flexible region is: Inclined to the opposite phase relative to the generally folded flexible member of the adjacent flexible area;
The first embodiment of the unexpanded stent upon expansion of the form of the second expanded state, each zone of the flexibility, and even stretched due to the inclined with shortened in the longitudinal direction, the entire stent The longitudinal length is maintained,
Stent.
請求項1に記載のステントにおいて、前記柔軟性の区域が接続部材により前記円柱状の区域に接続しており、当該接続部材が、前記長手方向に見た場合に、一つの円柱状の区域または一つの柔軟性の区域を挟んで隣接する接続部材に関し、互いに反対に位相ずれしている、ステント。The stent according to claim 1 , wherein the flexible region is connected to the cylindrical region by a connecting member, and when the connecting member is viewed in the longitudinal direction, one cylindrical region or A stent that is oppositely out of phase with respect to adjacent connecting members across a flexible region.
JP2002056192A 2001-03-02 2002-03-01 Flexible stent Expired - Lifetime JP4846172B2 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US797641 1991-11-25
US09/797,816 US6942689B2 (en) 2001-03-01 2001-03-02 Flexible stent
US09/797,640 US6679911B2 (en) 2001-03-01 2001-03-02 Flexible stent
US09/797,815 US6998060B2 (en) 2001-03-01 2001-03-02 Flexible stent and method of manufacture
US09/797,753 US6790227B2 (en) 2001-03-01 2001-03-02 Flexible stent
US09/797,641 US6740114B2 (en) 2001-03-01 2001-03-02 Flexible stent

Publications (3)

Publication Number Publication Date
JP2003010340A JP2003010340A (en) 2003-01-14
JP2003010340A5 JP2003010340A5 (en) 2008-12-25
JP4846172B2 true JP4846172B2 (en) 2011-12-28

Family

ID=39790624

Family Applications (5)

Application Number Title Priority Date Filing Date
JP2002056192A Expired - Lifetime JP4846172B2 (en) 2001-03-02 2002-03-01 Flexible stent
JP2002056161A Expired - Lifetime JP4731786B2 (en) 2001-03-02 2002-03-01 Flexible stent
JP2002056236A Expired - Fee Related JP4271403B2 (en) 2001-03-02 2002-03-01 Flexible stent
JP2002056270A Expired - Fee Related JP4354147B2 (en) 2001-03-02 2002-03-01 Flexible stent
JP2002056214A Expired - Fee Related JP4372390B2 (en) 2001-03-02 2002-03-01 Flexible stent

Family Applications After (4)

Application Number Title Priority Date Filing Date
JP2002056161A Expired - Lifetime JP4731786B2 (en) 2001-03-02 2002-03-01 Flexible stent
JP2002056236A Expired - Fee Related JP4271403B2 (en) 2001-03-02 2002-03-01 Flexible stent
JP2002056270A Expired - Fee Related JP4354147B2 (en) 2001-03-02 2002-03-01 Flexible stent
JP2002056214A Expired - Fee Related JP4372390B2 (en) 2001-03-02 2002-03-01 Flexible stent

Country Status (9)

Country Link
US (1) US6679911B2 (en)
EP (5) EP1236449A3 (en)
JP (5) JP4846172B2 (en)
AT (3) ATE353612T1 (en)
AU (5) AU785306B2 (en)
CA (5) CA2374200C (en)
DE (3) DE60205790T2 (en)
ES (2) ES2247270T3 (en)
MX (5) MXPA02002399A (en)

Families Citing this family (156)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7204848B1 (en) 1995-03-01 2007-04-17 Boston Scientific Scimed, Inc. Longitudinally flexible expandable stent
US7070590B1 (en) 1996-07-02 2006-07-04 Massachusetts Institute Of Technology Microchip drug delivery devices
US6692483B2 (en) 1996-11-04 2004-02-17 Advanced Stent Technologies, Inc. Catheter with attached flexible side sheath
US8211167B2 (en) 1999-12-06 2012-07-03 Boston Scientific Scimed, Inc. Method of using a catheter with attached flexible side sheath
US6835203B1 (en) 1996-11-04 2004-12-28 Advanced Stent Technologies, Inc. Extendible stent apparatus
US7591846B2 (en) * 1996-11-04 2009-09-22 Boston Scientific Scimed, Inc. Methods for deploying stents in bifurcations
US6599316B2 (en) 1996-11-04 2003-07-29 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6325826B1 (en) 1998-01-14 2001-12-04 Advanced Stent Technologies, Inc. Extendible stent apparatus
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US7713297B2 (en) 1998-04-11 2010-05-11 Boston Scientific Scimed, Inc. Drug-releasing stent with ceramic-containing layer
US7815763B2 (en) * 2001-09-28 2010-10-19 Abbott Laboratories Vascular Enterprises Limited Porous membranes for medical implants and methods of manufacture
US20020019660A1 (en) * 1998-09-05 2002-02-14 Marc Gianotti Methods and apparatus for a curved stent
US6682554B2 (en) 1998-09-05 2004-01-27 Jomed Gmbh Methods and apparatus for a stent having an expandable web structure
US7887578B2 (en) * 1998-09-05 2011-02-15 Abbott Laboratories Vascular Enterprises Limited Stent having an expandable web structure
US6755856B2 (en) 1998-09-05 2004-06-29 Abbott Laboratories Vascular Enterprises Limited Methods and apparatus for stenting comprising enhanced embolic protection, coupled with improved protection against restenosis and thrombus formation
US7655030B2 (en) 2003-07-18 2010-02-02 Boston Scientific Scimed, Inc. Catheter balloon systems and methods
US7387639B2 (en) * 1999-06-04 2008-06-17 Advanced Stent Technologies, Inc. Short sleeve stent delivery catheter and methods
JP2003513755A (en) * 1999-11-17 2003-04-15 マイクロチップス・インコーポレーテッド Microfabricated device for delivery of molecules into a carrier fluid
US8070792B2 (en) * 2000-09-22 2011-12-06 Boston Scientific Scimed, Inc. Stent
AU2001296297A1 (en) 2000-09-23 2002-04-02 G. David Jang Intravascular stent
DE10118944B4 (en) * 2001-04-18 2013-01-31 Merit Medical Systems, Inc. Removable, essentially cylindrical implants
US8617231B2 (en) 2001-05-18 2013-12-31 Boston Scientific Scimed, Inc. Dual guidewire exchange catheter system
US20020198589A1 (en) * 2001-06-22 2002-12-26 Leong Veronica Jade Tessellated stent and method of manufacture
DE60236093D1 (en) * 2001-07-26 2010-06-02 Merit Medical Systems Inc REMOVABLE STENT
US7842083B2 (en) * 2001-08-20 2010-11-30 Innovational Holdings, Llc. Expandable medical device with improved spatial distribution
EP1516600B1 (en) * 2001-09-18 2007-03-14 Abbott Laboratories Vascular Enterprises Limited Stent
JP3605388B2 (en) * 2001-10-16 2004-12-22 川澄化学工業株式会社 Stent
US6761731B2 (en) * 2002-06-28 2004-07-13 Cordis Corporation Balloon-stent interaction to help reduce foreshortening
US20060129227A1 (en) * 2002-08-02 2006-06-15 Auxetica Limited Auxetic tubular liners
US20040093056A1 (en) * 2002-10-26 2004-05-13 Johnson Lianw M. Medical appliance delivery apparatus and method of use
US7637942B2 (en) * 2002-11-05 2009-12-29 Merit Medical Systems, Inc. Coated stent with geometry determinated functionality and method of making the same
US7959671B2 (en) * 2002-11-05 2011-06-14 Merit Medical Systems, Inc. Differential covering and coating methods
US7527644B2 (en) * 2002-11-05 2009-05-05 Alveolus Inc. Stent with geometry determinated functionality and method of making the same
US7875068B2 (en) 2002-11-05 2011-01-25 Merit Medical Systems, Inc. Removable biliary stent
NL1021969C2 (en) * 2002-11-21 2004-05-26 Eugene Christian Olgers Device for introduction into a human body.
US20040158314A1 (en) * 2002-12-24 2004-08-12 Novostent Corporation Ribbon-type vascular prosthesis having stress-relieving articulation and methods of use
US7846198B2 (en) * 2002-12-24 2010-12-07 Novostent Corporation Vascular prosthesis and methods of use
US20050165469A1 (en) * 2002-12-24 2005-07-28 Michael Hogendijk Vascular prosthesis including torsional stabilizer and methods of use
US20050033410A1 (en) * 2002-12-24 2005-02-10 Novostent Corporation Vascular prothesis having flexible configuration
US20040160685A1 (en) * 2003-01-27 2004-08-19 Everardo Daniel Faires Quiros Lower rear view mirror (LRVM for short)
MXPA05009823A (en) * 2003-03-19 2006-03-13 Advanced Bio Prosthetic Surfac Endoluminal stent having mid-interconnecting members.
US7637934B2 (en) * 2003-03-31 2009-12-29 Merit Medical Systems, Inc. Medical appliance optical delivery and deployment apparatus and method
WO2004096340A1 (en) * 2003-04-30 2004-11-11 Nipro Corporation Extendable soft stent with excellent follow-up capability to blood vessel
US7604660B2 (en) * 2003-05-01 2009-10-20 Merit Medical Systems, Inc. Bifurcated medical appliance delivery apparatus and method
US7776078B2 (en) * 2003-05-22 2010-08-17 Boston Scientfic Scimed, Inc. Catheter balloon with improved retention
US20050021127A1 (en) * 2003-07-21 2005-01-27 Kawula Paul John Porous glass fused onto stent for drug retention
US8298280B2 (en) 2003-08-21 2012-10-30 Boston Scientific Scimed, Inc. Stent with protruding branch portion for bifurcated vessels
US7247166B2 (en) * 2003-09-29 2007-07-24 Advanced Cardiovascular Systems, Inc. Intravascular stent with extendible end rings
US7344557B2 (en) 2003-11-12 2008-03-18 Advanced Stent Technologies, Inc. Catheter balloon systems and methods
US8858616B2 (en) 2004-03-16 2014-10-14 Admedes Schuessler Gmbh Stent having a bridge structure
DE102004012837B4 (en) * 2004-03-16 2006-09-14 Admedes Schuessler Gmbh Stent having a web structure and method of making the same
US7328701B2 (en) * 2004-04-07 2008-02-12 Green Philip A Variable size endotracheal tube
US7763064B2 (en) * 2004-06-08 2010-07-27 Medinol, Ltd. Stent having struts with reverse direction curvature
EP1773871B1 (en) 2004-06-17 2014-10-15 Thrasos Innovation, Inc. Tdf-related compounds and analogs thereof
WO2006024489A2 (en) 2004-08-30 2006-03-09 Interstitial Therapeutics Methods and compositions for the treatment of cell proliferation
WO2006035669A1 (en) * 2004-09-28 2006-04-06 Nipro Corporation Soft stent excellent in vascular follow-up and dilation nature
US7887579B2 (en) * 2004-09-29 2011-02-15 Merit Medical Systems, Inc. Active stent
CN102309370B (en) * 2005-04-04 2015-04-15 灵活支架解决方案股份有限公司 Flexible stent
US7731654B2 (en) * 2005-05-13 2010-06-08 Merit Medical Systems, Inc. Delivery device with viewing window and associated method
EP2497780B1 (en) 2005-09-20 2015-04-15 Thrasos Innovation, Inc. TDF-related compounds and analogs thereof
EP1948101B1 (en) * 2005-11-07 2011-12-21 Cook Medical Technologies LLC Stent with orientation-dependent properties
US8821561B2 (en) * 2006-02-22 2014-09-02 Boston Scientific Scimed, Inc. Marker arrangement for bifurcation catheter
US8828077B2 (en) * 2006-03-15 2014-09-09 Medinol Ltd. Flat process of preparing drug eluting stents
US20070224235A1 (en) 2006-03-24 2007-09-27 Barron Tenney Medical devices having nanoporous coatings for controlled therapeutic agent delivery
US8187620B2 (en) 2006-03-27 2012-05-29 Boston Scientific Scimed, Inc. Medical devices comprising a porous metal oxide or metal material and a polymer coating for delivering therapeutic agents
US20070275035A1 (en) * 2006-05-24 2007-11-29 Microchips, Inc. Minimally Invasive Medical Implant Devices for Controlled Drug Delivery
EP2020956A2 (en) 2006-05-26 2009-02-11 Nanyang Technological University Implantable article, method of forming same and method for reducing thrombogenicity
US20070282433A1 (en) * 2006-06-01 2007-12-06 Limon Timothy A Stent with retention protrusions formed during crimping
US8815275B2 (en) 2006-06-28 2014-08-26 Boston Scientific Scimed, Inc. Coatings for medical devices comprising a therapeutic agent and a metallic material
WO2008002778A2 (en) 2006-06-29 2008-01-03 Boston Scientific Limited Medical devices with selective coating
DE07841109T1 (en) * 2006-08-22 2010-02-11 Abbott Cardiovascular Systems Inc., Santa Clara INTRAVASCULAR STENT
US8882826B2 (en) 2006-08-22 2014-11-11 Abbott Cardiovascular Systems Inc. Intravascular stent
US8834554B2 (en) 2006-08-22 2014-09-16 Abbott Cardiovascular Systems Inc. Intravascular stent
ATE508708T1 (en) 2006-09-14 2011-05-15 Boston Scient Ltd MEDICAL DEVICES WITH A DRUG-RELEASING COATING
US8778009B2 (en) * 2006-10-06 2014-07-15 Abbott Cardiovascular Systems Inc. Intravascular stent
US7981150B2 (en) 2006-11-09 2011-07-19 Boston Scientific Scimed, Inc. Endoprosthesis with coatings
US8431149B2 (en) 2007-03-01 2013-04-30 Boston Scientific Scimed, Inc. Coated medical devices for abluminal drug delivery
US8070797B2 (en) 2007-03-01 2011-12-06 Boston Scientific Scimed, Inc. Medical device with a porous surface for delivery of a therapeutic agent
US8974514B2 (en) 2007-03-13 2015-03-10 Abbott Cardiovascular Systems Inc. Intravascular stent with integrated link and ring strut
US8067054B2 (en) 2007-04-05 2011-11-29 Boston Scientific Scimed, Inc. Stents with ceramic drug reservoir layer and methods of making and using the same
US8128679B2 (en) 2007-05-23 2012-03-06 Abbott Laboratories Vascular Enterprises Limited Flexible stent with torque-absorbing connectors
US7976915B2 (en) 2007-05-23 2011-07-12 Boston Scientific Scimed, Inc. Endoprosthesis with select ceramic morphology
US8016874B2 (en) * 2007-05-23 2011-09-13 Abbott Laboratories Vascular Enterprises Limited Flexible stent with elevated scaffolding properties
US8002823B2 (en) 2007-07-11 2011-08-23 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7942926B2 (en) 2007-07-11 2011-05-17 Boston Scientific Scimed, Inc. Endoprosthesis coating
EP2187988B1 (en) 2007-07-19 2013-08-21 Boston Scientific Limited Endoprosthesis having a non-fouling surface
US7931683B2 (en) 2007-07-27 2011-04-26 Boston Scientific Scimed, Inc. Articles having ceramic coated surfaces
US8815273B2 (en) 2007-07-27 2014-08-26 Boston Scientific Scimed, Inc. Drug eluting medical devices having porous layers
WO2009018340A2 (en) 2007-07-31 2009-02-05 Boston Scientific Scimed, Inc. Medical device coating by laser cladding
US8486134B2 (en) 2007-08-01 2013-07-16 Boston Scientific Scimed, Inc. Bifurcation treatment system and methods
JP2010535541A (en) 2007-08-03 2010-11-25 ボストン サイエンティフィック リミテッド Coating for medical devices with large surface area
US20090082841A1 (en) * 2007-09-26 2009-03-26 Boston Scientific Corporation Apparatus for securing stent barbs
US8226701B2 (en) 2007-09-26 2012-07-24 Trivascular, Inc. Stent and delivery system for deployment thereof
US8663309B2 (en) * 2007-09-26 2014-03-04 Trivascular, Inc. Asymmetric stent apparatus and method
US8066755B2 (en) * 2007-09-26 2011-11-29 Trivascular, Inc. System and method of pivoted stent deployment
AU2008308474B2 (en) 2007-10-04 2014-07-24 Trivascular, Inc. Modular vascular graft for low profile percutaneous delivery
US8216632B2 (en) 2007-11-02 2012-07-10 Boston Scientific Scimed, Inc. Endoprosthesis coating
US7938855B2 (en) 2007-11-02 2011-05-10 Boston Scientific Scimed, Inc. Deformable underlayer for stent
US8029554B2 (en) 2007-11-02 2011-10-04 Boston Scientific Scimed, Inc. Stent with embedded material
US8083789B2 (en) * 2007-11-16 2011-12-27 Trivascular, Inc. Securement assembly and method for expandable endovascular device
US8328861B2 (en) 2007-11-16 2012-12-11 Trivascular, Inc. Delivery system and method for bifurcated graft
US7833266B2 (en) 2007-11-28 2010-11-16 Boston Scientific Scimed, Inc. Bifurcated stent with drug wells for specific ostial, carina, and side branch treatment
US7896911B2 (en) 2007-12-12 2011-03-01 Innovasc Llc Device and method for tacking plaque to blood vessel wall
US10166127B2 (en) 2007-12-12 2019-01-01 Intact Vascular, Inc. Endoluminal device and method
US8128677B2 (en) 2007-12-12 2012-03-06 Intact Vascular LLC Device and method for tacking plaque to a blood vessel wall
US10022250B2 (en) 2007-12-12 2018-07-17 Intact Vascular, Inc. Deployment device for placement of multiple intraluminal surgical staples
US7850726B2 (en) * 2007-12-20 2010-12-14 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having struts linked by foot extensions
US20090163998A1 (en) * 2007-12-20 2009-06-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having rings linked by foot extensions
WO2009086200A1 (en) * 2007-12-20 2009-07-09 Trivascular2, Inc. Hinged endovascular device
US8920488B2 (en) * 2007-12-20 2014-12-30 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having a stable architecture
US8337544B2 (en) * 2007-12-20 2012-12-25 Abbott Laboratories Vascular Enterprises Limited Endoprosthesis having flexible connectors
JP5504173B2 (en) * 2007-12-31 2014-05-28 ボストン サイエンティフィック サイムド,インコーポレイテッド Catheter assembly for vascular bifurcation treatment
EP2271380B1 (en) 2008-04-22 2013-03-20 Boston Scientific Scimed, Inc. Medical devices having a coating of inorganic material
WO2009132176A2 (en) 2008-04-24 2009-10-29 Boston Scientific Scimed, Inc. Medical devices having inorganic particle layers
US8377108B2 (en) 2008-06-02 2013-02-19 Boston Scientific Scimed, Inc. Staggered two balloon bifurcation catheter assembly and methods
JP5662310B2 (en) * 2008-06-05 2015-01-28 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Shrinkable branch device and method of manufacturing the same
WO2009149405A1 (en) * 2008-06-05 2009-12-10 Boston Scientific Scimed, Inc. Balloon bifurcated lumen treatment
EP2303350A2 (en) 2008-06-18 2011-04-06 Boston Scientific Scimed, Inc. Endoprosthesis coating
US10898620B2 (en) 2008-06-20 2021-01-26 Razmodics Llc Composite stent having multi-axial flexibility and method of manufacture thereof
US8206636B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US8206635B2 (en) 2008-06-20 2012-06-26 Amaranth Medical Pte. Stent fabrication via tubular casting processes
US7951193B2 (en) 2008-07-23 2011-05-31 Boston Scientific Scimed, Inc. Drug-eluting stent
US8231980B2 (en) 2008-12-03 2012-07-31 Boston Scientific Scimed, Inc. Medical implants including iridium oxide
US8071156B2 (en) 2009-03-04 2011-12-06 Boston Scientific Scimed, Inc. Endoprostheses
CA2757627C (en) * 2009-04-10 2014-10-28 Ev3 Inc. Implants having high fatigue resistance, implant delivery systems, and methods of use
US8287937B2 (en) 2009-04-24 2012-10-16 Boston Scientific Scimed, Inc. Endoprosthese
US20100292777A1 (en) * 2009-05-13 2010-11-18 Boston Scientific Scimed, Inc. Stent
JP4852631B2 (en) * 2009-06-28 2012-01-11 株式会社沖データ Communication device and connection control method thereof
US8298279B2 (en) * 2009-09-24 2012-10-30 Medtronic Vascular, Inc. Stent including a toggle lock strut
WO2011100367A2 (en) * 2010-02-10 2011-08-18 Trivascular, Inc. Fill tube manifold and delivery methods for endovascular graft
US8882824B2 (en) * 2010-04-20 2014-11-11 Cg Bio Co., Ltd. Expanding vascular stent
US10271973B2 (en) 2011-06-03 2019-04-30 Intact Vascular, Inc. Endovascular implant
CN104159544B (en) * 2012-03-07 2017-05-24 奥巴斯尼茨医学公司 Medical device for implantation into luminal structures
US8992595B2 (en) 2012-04-04 2015-03-31 Trivascular, Inc. Durable stent graft with tapered struts and stable delivery methods and devices
US9498363B2 (en) 2012-04-06 2016-11-22 Trivascular, Inc. Delivery catheter for endovascular device
NZ701992A (en) * 2012-05-14 2016-03-31 Bard Inc C R Uniformly expandable stent
DE102012220129B4 (en) * 2012-11-05 2022-12-15 Optimed Medizinische Lnstrumente Gmbh stent
EP3010451B1 (en) 2013-06-21 2021-11-24 Boston Scientific Scimed, Inc. Stent with deflecting connector
US9433520B2 (en) 2015-01-29 2016-09-06 Intact Vascular, Inc. Delivery device and method of delivery
US9375336B1 (en) 2015-01-29 2016-06-28 Intact Vascular, Inc. Delivery device and method of delivery
US10993824B2 (en) 2016-01-01 2021-05-04 Intact Vascular, Inc. Delivery device and method of delivery
US10265089B2 (en) 2016-02-12 2019-04-23 Covidien Lp Vascular device visibility
US10052185B2 (en) 2016-02-12 2018-08-21 Covidien Lp Vascular device marker attachment
EP3435930B1 (en) 2016-03-31 2022-11-30 Vesper Medical, Inc. Intravascular implants
US11660218B2 (en) 2017-07-26 2023-05-30 Intact Vascular, Inc. Delivery device and method of delivery
US10849769B2 (en) 2017-08-23 2020-12-01 Vesper Medical, Inc. Non-foreshortening stent
US10271977B2 (en) 2017-09-08 2019-04-30 Vesper Medical, Inc. Hybrid stent
US11628076B2 (en) 2017-09-08 2023-04-18 Vesper Medical, Inc. Hybrid stent
US11357650B2 (en) 2019-02-28 2022-06-14 Vesper Medical, Inc. Hybrid stent
US10835398B2 (en) * 2017-11-03 2020-11-17 Covidien Lp Meshes and devices for treating vascular defects
US11364134B2 (en) 2018-02-15 2022-06-21 Vesper Medical, Inc. Tapering stent
US10500078B2 (en) 2018-03-09 2019-12-10 Vesper Medical, Inc. Implantable stent
CA3101165A1 (en) 2018-05-23 2019-11-28 Sorin Group Italia S.R.L. A cardiac valve prosthesis
US11684498B2 (en) 2018-10-19 2023-06-27 Inspire M.D Ltd. Methods of using a self-adjusting stent assembly and kits including same
US20230000648A1 (en) * 2021-05-20 2023-01-05 Cook Medical Technologies Llc Self expanding stents and methods
WO2022245435A1 (en) * 2021-05-20 2022-11-24 Cook Medical Technologies Llc Self expanding stent and method of loading same into a catheter

Family Cites Families (150)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1205743A (en) 1916-05-25 1916-11-21 Uriah Hoke Filter.
FR566807A (en) 1923-01-12 1924-02-21 Improvements in the use of gases escaping from water tube boilers
US3657744A (en) 1970-05-08 1972-04-25 Univ Minnesota Method for fixing prosthetic implants in a living body
US4388735A (en) 1980-11-03 1983-06-21 Shiley Inc. Low profile prosthetic xenograft heart valve
GB2124908B (en) 1981-09-16 1985-07-17 Hans Ivar Wallsten Device for application in blood vessels or other difficultly accessible locations
DE3205942A1 (en) 1982-02-19 1983-09-08 Ljubomir Dr. Skopje Vasilev Balloon-tipped catheter with a mobile tip which permits complete voiding of the bladder
DE3225206C1 (en) * 1982-07-06 1983-10-27 Dr. Johannes Heidenhain Gmbh, 8225 Traunreut Process for the single-sided etching of plates
US4503569A (en) 1983-03-03 1985-03-12 Dotter Charles T Transluminally placed expandable graft prosthesis
US5275622A (en) 1983-12-09 1994-01-04 Harrison Medical Technologies, Inc. Endovascular grafting apparatus, system and method and devices for use therewith
US4580568A (en) 1984-10-01 1986-04-08 Cook, Incorporated Percutaneous endovascular stent and method for insertion thereof
US4733665C2 (en) 1985-11-07 2002-01-29 Expandable Grafts Partnership Expandable intraluminal graft and method and apparatus for implanting an expandable intraluminal graft
US5102417A (en) 1985-11-07 1992-04-07 Expandable Grafts Partnership Expandable intraluminal graft, and method and apparatus for implanting an expandable intraluminal graft
US5041126A (en) 1987-03-13 1991-08-20 Cook Incorporated Endovascular stent and delivery system
US4907336A (en) 1987-03-13 1990-03-13 Cook Incorporated Method of making an endovascular stent and delivery system
US4800882A (en) 1987-03-13 1989-01-31 Cook Incorporated Endovascular stent and delivery system
US4969458A (en) 1987-07-06 1990-11-13 Medtronic, Inc. Intracoronary stent and method of simultaneous angioplasty and stent implant
US4990131A (en) 1987-09-01 1991-02-05 Herbert Dardik Tubular prostheses for vascular reconstructive surgery and process for preparing same
US5131908A (en) 1987-09-01 1992-07-21 Herbert Dardik Tubular prosthesis for vascular reconstructive surgery and process for preparing same
US4886062A (en) 1987-10-19 1989-12-12 Medtronic, Inc. Intravascular radially expandable stent and method of implant
US5133732A (en) 1987-10-19 1992-07-28 Medtronic, Inc. Intravascular stent
US5266073A (en) 1987-12-08 1993-11-30 Wall W Henry Angioplasty stent
US5192307A (en) 1987-12-08 1993-03-09 Wall W Henry Angioplasty stent
CA1322628C (en) 1988-10-04 1993-10-05 Richard A. Schatz Expandable intraluminal graft
US4856516A (en) 1989-01-09 1989-08-15 Cordis Corporation Endovascular stent apparatus and method
CH678393A5 (en) 1989-01-26 1991-09-13 Ulrich Prof Dr Med Sigwart
US5163958A (en) 1989-02-02 1992-11-17 Cordis Corporation Carbon coated tubular endoprosthesis
US4990155A (en) 1989-05-19 1991-02-05 Wilkoff Howard M Surgical stent method and apparatus
US4994071A (en) 1989-05-22 1991-02-19 Cordis Corporation Bifurcating stent apparatus and method
US5015253A (en) 1989-06-15 1991-05-14 Cordis Corporation Non-woven endoprosthesis
US5171262A (en) 1989-06-15 1992-12-15 Cordis Corporation Non-woven endoprosthesis
US5292331A (en) 1989-08-24 1994-03-08 Applied Vascular Engineering, Inc. Endovascular support device
IE73670B1 (en) 1989-10-02 1997-07-02 Medtronic Inc Articulated stent
US5035706A (en) 1989-10-17 1991-07-30 Cook Incorporated Percutaneous stent and method for retrieval thereof
US5176660A (en) 1989-10-23 1993-01-05 Cordis Corporation Catheter having reinforcing strands
IL94138A (en) 1990-04-19 1997-03-18 Instent Inc Device for the treatment of constricted fluid conducting ducts
US5064435A (en) 1990-06-28 1991-11-12 Schneider (Usa) Inc. Self-expanding prosthesis having stable axial length
US5122154A (en) 1990-08-15 1992-06-16 Rhodes Valentine J Endovascular bypass graft
ES2085435T3 (en) 1990-10-09 1996-06-01 Cook Inc PERCUTANEOUS DILATOR DEVICE.
US5222971A (en) 1990-10-09 1993-06-29 Scimed Life Systems, Inc. Temporary stent and methods for use and manufacture
US5449372A (en) 1990-10-09 1995-09-12 Scimed Lifesystems, Inc. Temporary stent and methods for use and manufacture
US5217483A (en) 1990-11-28 1993-06-08 Numed, Inc. Intravascular radially expandable stent
US5178618A (en) 1991-01-16 1993-01-12 Brigham And Womens Hospital Method and device for recanalization of a body passageway
US5354257A (en) 1991-01-29 1994-10-11 Med Institute, Inc. Minimally invasive medical device for providing a radiation treatment
US5135536A (en) 1991-02-05 1992-08-04 Cordis Corporation Endovascular stent and method
US5116365A (en) 1991-02-22 1992-05-26 Cordis Corporation Stent apparatus and method for making
US5304200A (en) 1991-05-29 1994-04-19 Cordis Corporation Welded radially expandable endoprosthesis and the like
US5314472A (en) 1991-10-01 1994-05-24 Cook Incorporated Vascular stent
US5527354A (en) 1991-06-28 1996-06-18 Cook Incorporated Stent formed of half-round wire
USD359802S (en) 1991-06-28 1995-06-27 Cook Incorporated Vascular stent
US5443498A (en) 1991-10-01 1995-08-22 Cook Incorporated Vascular stent and method of making and implanting a vacsular stent
US5366504A (en) 1992-05-20 1994-11-22 Boston Scientific Corporation Tubular medical prosthesis
US5290305A (en) 1991-10-11 1994-03-01 Kanji Inoue Appliance collapsible for insertion into human organs and capable of resilient restoration
US5387235A (en) 1991-10-25 1995-02-07 Cook Incorporated Expandable transluminal graft prosthesis for repair of aneurysm
CA2079417C (en) 1991-10-28 2003-01-07 Lilip Lau Expandable stents and method of making same
US5258021A (en) 1992-01-27 1993-11-02 Duran Carlos G Sigmoid valve annuloplasty ring
CA2087132A1 (en) 1992-01-31 1993-08-01 Michael S. Williams Stent capable of attachment within a body lumen
US5405377A (en) 1992-02-21 1995-04-11 Endotech Ltd. Intraluminal stent
DE4206843C2 (en) 1992-03-04 1994-03-24 Heraeus Elektrochemie Electrochemical cells for performing electrochemical processes
US5282823A (en) 1992-03-19 1994-02-01 Medtronic, Inc. Intravascular radially expandable stent
US5370683A (en) 1992-03-25 1994-12-06 Cook Incorporated Vascular stent
FR2689388B1 (en) 1992-04-07 1999-07-16 Celsa Lg PERFECTIONALLY RESORBABLE BLOOD FILTER.
WO1995014500A1 (en) 1992-05-01 1995-06-01 Beth Israel Hospital A stent
US5354308A (en) 1992-05-01 1994-10-11 Beth Israel Hospital Association Metal wire stent
US5342387A (en) 1992-06-18 1994-08-30 American Biomed, Inc. Artificial support for a blood vessel
US5496365A (en) 1992-07-02 1996-03-05 Sgro; Jean-Claude Autoexpandable vascular endoprosthesis
US5382261A (en) 1992-09-01 1995-01-17 Expandable Grafts Partnership Method and apparatus for occluding vessels
US5449382A (en) 1992-11-04 1995-09-12 Dayton; Michael P. Minimally invasive bioactivated endoprosthesis for vessel repair
BE1006440A3 (en) 1992-12-21 1994-08-30 Dereume Jean Pierre Georges Em Luminal endoprosthesis AND METHOD OF PREPARATION.
US5370691A (en) 1993-01-26 1994-12-06 Target Therapeutics, Inc. Intravascular inflatable stent
US5441515A (en) 1993-04-23 1995-08-15 Advanced Cardiovascular Systems, Inc. Ratcheting stent
US5411549A (en) 1993-07-13 1995-05-02 Scimed Life Systems, Inc. Selectively expandable, retractable and removable stent
US5389106A (en) 1993-10-29 1995-02-14 Numed, Inc. Impermeable expandable intravascular stent
JP2703510B2 (en) 1993-12-28 1998-01-26 アドヴァンスド カーディオヴァスキュラー システムズ インコーポレーテッド Expandable stent and method of manufacturing the same
US5403341A (en) 1994-01-24 1995-04-04 Solar; Ronald J. Parallel flow endovascular stent and deployment apparatus therefore
US5609627A (en) 1994-02-09 1997-03-11 Boston Scientific Technology, Inc. Method for delivering a bifurcated endoluminal prosthesis
US5643312A (en) 1994-02-25 1997-07-01 Fischell Robert Stent having a multiplicity of closed circular structures
US5441516A (en) 1994-03-03 1995-08-15 Scimed Lifesystems Inc. Temporary stent
US5733303A (en) 1994-03-17 1998-03-31 Medinol Ltd. Flexible expandable stent
US5449373A (en) 1994-03-17 1995-09-12 Medinol Ltd. Articulated stent
US5843120A (en) 1994-03-17 1998-12-01 Medinol Ltd. Flexible-expandable stent
US6001123A (en) 1994-04-01 1999-12-14 Gore Enterprise Holdings Inc. Folding self-expandable intravascular stent-graft
JP3577353B2 (en) * 1995-01-27 2004-10-13 テルモ株式会社 In-vivo stent
US5397355A (en) 1994-07-19 1995-03-14 Stentco, Inc. Intraluminal stent
US5836964A (en) 1996-10-30 1998-11-17 Medinol Ltd. Stent fabrication method
US5549662A (en) * 1994-11-07 1996-08-27 Scimed Life Systems, Inc. Expandable stent using sliding members
NL9500094A (en) 1995-01-19 1996-09-02 Industrial Res Bv Y-shaped stent and method of deployment.
US5591197A (en) * 1995-03-14 1997-01-07 Advanced Cardiovascular Systems, Inc. Expandable stent forming projecting barbs and method for deploying
ES2119527T5 (en) 1995-04-01 2006-11-16 Variomed Ag STENT DEVICE FOR TRANSLUMINAL IMPLEMENTATION IN HOLLOW ORGANS.
US6602281B1 (en) * 1995-06-05 2003-08-05 Avantec Vascular Corporation Radially expansible vessel scaffold having beams and expansion joints
US5776161A (en) 1995-10-16 1998-07-07 Instent, Inc. Medical stents, apparatus and method for making same
US5669924A (en) 1995-10-26 1997-09-23 Shaknovich; Alexander Y-shuttle stent assembly for bifurcating vessels and method of using the same
US6203569B1 (en) * 1996-01-04 2001-03-20 Bandula Wijay Flexible stent
US5695516A (en) 1996-02-21 1997-12-09 Iso Stent, Inc. Longitudinally elongating balloon expandable stent
CA2192520A1 (en) 1996-03-05 1997-09-05 Ian M. Penn Expandable stent and method for delivery of same
DE19614160A1 (en) 1996-04-10 1997-10-16 Variomed Ag Stent for transluminal implantation in hollow organs
NZ331269A (en) * 1996-04-10 2000-01-28 Advanced Cardiovascular System Expandable stent, its structural strength varying along its length
US5922021A (en) 1996-04-26 1999-07-13 Jang; G. David Intravascular stent
US6152957A (en) 1996-04-26 2000-11-28 Jang; G. David Intravascular stent
UA58485C2 (en) 1996-05-03 2003-08-15 Медінол Лтд. Method for manufacture of bifurcated stent (variants) and bifurcated stent (variants)
US5697971A (en) 1996-06-11 1997-12-16 Fischell; Robert E. Multi-cell stent with cells having differing characteristics
US5922020A (en) 1996-08-02 1999-07-13 Localmed, Inc. Tubular prosthesis having improved expansion and imaging characteristics
US5755781A (en) 1996-08-06 1998-05-26 Iowa-India Investments Company Limited Embodiments of multiple interconnected stents
US5776183A (en) 1996-08-23 1998-07-07 Kanesaka; Nozomu Expandable stent
US5807404A (en) 1996-09-19 1998-09-15 Medinol Ltd. Stent with variable features to optimize support and method of making such stent
US5755776A (en) 1996-10-04 1998-05-26 Al-Saadon; Khalid Permanent expandable intraluminal tubular stent
US5868781A (en) 1996-10-22 1999-02-09 Scimed Life Systems, Inc. Locking stent
DE29701758U1 (en) 1997-02-01 1997-03-27 Jomed Implantate GmbH, 72414 Rangendingen Radially expandable stent for implantation in a body vessel, particularly in the area of a vascular branch
US5827321A (en) 1997-02-07 1998-10-27 Cornerstone Devices, Inc. Non-Foreshortening intraluminal prosthesis
DE29702671U1 (en) 1997-02-17 1997-04-10 Jomed Implantate GmbH, 72414 Rangendingen Stent
WO1998038946A1 (en) * 1997-03-05 1998-09-11 Stent Tech, Inc. Expandable and self-expanding stents and methods of making and using the same
US5810872A (en) 1997-03-14 1998-09-22 Kanesaka; Nozomu Flexible stent
US5902475A (en) * 1997-04-08 1999-05-11 Interventional Technologies, Inc. Method for manufacturing a stent
US5718713A (en) 1997-04-10 1998-02-17 Global Therapeutics, Inc. Surgical stent having a streamlined contour
US6033433A (en) 1997-04-25 2000-03-07 Scimed Life Systems, Inc. Stent configurations including spirals
IT1292295B1 (en) * 1997-04-29 1999-01-29 Sorin Biomedica Cardio Spa ANGIOPLASTIC STENT
US5741327A (en) 1997-05-06 1998-04-21 Global Therapeutics, Inc. Surgical stent featuring radiopaque markers
CA2308396A1 (en) * 1997-05-14 1998-11-19 Novo Rps Ulc Expandable stent and method for production of same
DE29708689U1 (en) 1997-05-15 1997-07-17 Jomed Implantate GmbH, 72414 Rangendingen Coronary stent
DE29708879U1 (en) 1997-05-20 1997-07-31 Jomed Implantate GmbH, 72414 Rangendingen Coronary stent
DE19722384A1 (en) 1997-05-28 1998-12-03 Gfe Ges Fuer Forschung Und Ent Flexible expandable stent
US5913895A (en) 1997-06-02 1999-06-22 Isostent, Inc. Intravascular stent with enhanced rigidity strut members
EP0884029B1 (en) * 1997-06-13 2004-12-22 Gary J. Becker Expandable intraluminal endoprosthesis
CA2241558A1 (en) 1997-06-24 1998-12-24 Advanced Cardiovascular Systems, Inc. Stent with reinforced struts and bimodal deployment
US5855600A (en) 1997-08-01 1999-01-05 Inflow Dynamics Inc. Flexible implantable stent with composite design
DE29716476U1 (en) 1997-09-13 1997-12-18 Convent, Gerd, 47829 Krefeld Stenosis treatment stent
JP4292710B2 (en) * 1997-09-24 2009-07-08 エム イー ディ インスチィチュート インク Radially expandable stent
US5948016A (en) 1997-09-25 1999-09-07 Jang; G. David Intravascular stent with non-parallel slots
US6033435A (en) 1997-11-03 2000-03-07 Divysio Solutions Ulc Bifurcated stent and method for the manufacture and delivery of same
US6309414B1 (en) 1997-11-04 2001-10-30 Sorin Biomedica Cardio S.P.A. Angioplasty stents
DE19753123B4 (en) * 1997-11-29 2006-11-09 B. Braun Melsungen Ag stent
US6129754A (en) 1997-12-11 2000-10-10 Uni-Cath Inc. Stent for vessel with branch
US6179867B1 (en) 1998-01-16 2001-01-30 Advanced Cardiovascular Systems, Inc. Flexible stent and method of use
US6113627A (en) * 1998-02-03 2000-09-05 Jang; G. David Tubular stent consists of horizontal expansion struts and contralaterally attached diagonal-connectors
AU2684499A (en) * 1998-02-17 1999-08-30 G. David Jang Tubular stent consists of chevron-shape expansion struts and ipsilaterally attached m-frame connectors
US5935162A (en) 1998-03-16 1999-08-10 Medtronic, Inc. Wire-tubular hybrid stent
US6241762B1 (en) * 1998-03-30 2001-06-05 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6019789A (en) 1998-04-01 2000-02-01 Quanam Medical Corporation Expandable unit cell and intraluminal stent
US6066169A (en) 1998-06-02 2000-05-23 Ave Connaught Expandable stent having articulated connecting rods
US6171334B1 (en) 1998-06-17 2001-01-09 Advanced Cardiovascular Systems, Inc. Expandable stent and method of use
DE19829702C1 (en) 1998-07-03 2000-03-16 Heraeus Gmbh W C Radially expandable support device V
US5911754A (en) 1998-07-24 1999-06-15 Uni-Cath Inc. Flexible stent with effective strut and connector patterns
US6293967B1 (en) 1998-10-29 2001-09-25 Conor Medsystems, Inc. Expandable medical device with ductile hinges
US6190403B1 (en) 1998-11-13 2001-02-20 Cordis Corporation Low profile radiopaque stent with increased longitudinal flexibility and radial rigidity
US6340366B2 (en) 1998-12-08 2002-01-22 Bandula Wijay Stent with nested or overlapping rings
US6325825B1 (en) * 1999-04-08 2001-12-04 Cordis Corporation Stent with variable wall thickness
US6245101B1 (en) * 1999-05-03 2001-06-12 William J. Drasler Intravascular hinge stent
CA2376069A1 (en) * 1999-06-30 2001-01-04 Orlando M. Padilla Variable thickness stent and method of manufacture thereof
DE19938377A1 (en) * 1999-08-06 2001-03-01 Biotronik Mess & Therapieg Stent for vascular branching
US20010047200A1 (en) * 1999-10-13 2001-11-29 Raymond Sun Non-foreshortening intraluminal prosthesis
WO2001041675A1 (en) * 1999-12-07 2001-06-14 Edwards Lifesciences Corporation Novel enhanced flexible expandable stents

Also Published As

Publication number Publication date
CA2374090C (en) 2007-05-01
ATE303110T1 (en) 2005-09-15
JP4271403B2 (en) 2009-06-03
EP1236449A3 (en) 2004-01-07
AU782766B2 (en) 2005-08-25
CA2374176C (en) 2010-02-09
EP1236449A2 (en) 2002-09-04
DE60205790T2 (en) 2006-06-22
MXPA02002402A (en) 2004-06-22
EP1236447B1 (en) 2007-02-14
EP1236448A3 (en) 2002-11-27
CA2374200A1 (en) 2002-09-02
MXPA02002401A (en) 2004-06-22
JP2003024451A (en) 2003-01-28
JP2003010341A (en) 2003-01-14
DE60205791D1 (en) 2005-10-06
EP1236445A2 (en) 2002-09-04
AU785306B2 (en) 2007-01-11
DE60218072T2 (en) 2007-10-31
JP2003010340A (en) 2003-01-14
JP4354147B2 (en) 2009-10-28
ATE303109T1 (en) 2005-09-15
ATE353612T1 (en) 2007-03-15
CA2374176A1 (en) 2002-09-02
AU1680602A (en) 2002-09-05
AU1680502A (en) 2002-09-05
ES2247269T3 (en) 2006-03-01
EP1236445B1 (en) 2010-11-03
JP2003000724A (en) 2003-01-07
EP1236446B1 (en) 2005-08-31
EP1236446A3 (en) 2002-11-27
CA2374090A1 (en) 2002-09-02
JP2003024449A (en) 2003-01-28
US20020123798A1 (en) 2002-09-05
JP4731786B2 (en) 2011-07-27
AU1680202A (en) 2002-09-05
EP1236448A2 (en) 2002-09-04
US6679911B2 (en) 2004-01-20
AU1680402A (en) 2002-09-05
EP1236445A3 (en) 2002-11-27
CA2374200C (en) 2007-04-10
EP1236446A2 (en) 2002-09-04
CA2374137A1 (en) 2002-09-02
AU782731B2 (en) 2005-08-25
DE60205790D1 (en) 2005-10-06
EP1236447A3 (en) 2004-01-21
MXPA02002399A (en) 2004-06-22
EP1236448B1 (en) 2005-08-31
MXPA02002403A (en) 2004-06-22
DE60205791T2 (en) 2006-05-18
CA2374113A1 (en) 2002-09-02
EP1236447A2 (en) 2002-09-04
DE60218072D1 (en) 2007-03-29
JP4372390B2 (en) 2009-11-25
AU1680702A (en) 2002-09-05
ES2247270T3 (en) 2006-03-01
MXPA02002398A (en) 2004-06-22

Similar Documents

Publication Publication Date Title
JP4846172B2 (en) Flexible stent
US6955686B2 (en) Flexible stent
US6998060B2 (en) Flexible stent and method of manufacture
US6790227B2 (en) Flexible stent
US7594927B2 (en) Flexible stent

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20050216

RD04 Notification of resignation of power of attorney

Free format text: JAPANESE INTERMEDIATE CODE: A7424

Effective date: 20071126

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20080513

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20080813

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20080818

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20081111

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20081111

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20090331

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090615

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20090812

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20090904

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20091009

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110404

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110706

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20111012

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141021

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 4846172

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R360 Written notification for declining of transfer of rights

Free format text: JAPANESE INTERMEDIATE CODE: R360

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313113

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

EXPY Cancellation because of completion of term